Maxim Integrated Products (MXIM) 10-Q 1 May 19 2019 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information Document - shares	3 Months Ended	9 Months Ended
	Mar. 30, 2019	Mar. 30, 2019	Apr. 18, 2019
DEI [Abstract]
Entity Registrant Name		MAXIM INTEGRATED PRODUCTS INC
Entity Central Index Key		0000743316
Trading Symbol	MXIM
Document Type		10-Q
Amendment Flag		false
Document Period End Date		Mar. 30, 2019
Document Fiscal Year Focus		2019
Document Fiscal Period Focus		Q3
Entity Emerging Growth Company	false
Entity Small Business	false
Current Fiscal Year End Date		--06-29
Entity Filer Category		Large Accelerated Filer
Entity Common Stock, Shares Outstanding			272,425,069

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	3 Months Ended
	Mar. 30, 2019	Jun. 30, 2018
Finite-Lived Intangible Assets, Gross	$ 617,825,000	$ 613,599,000
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	106,011,000
Current assets:
Cash and cash equivalents	1,654,563,000	1,543,484,000
Short-term Investments	243,864,000	1,082,915,000
Total cash, cash equivalents and short-term investments	1,898,427,000	2,626,399,000
Accounts receivable, net	381,152,000	280,072,000
Inventories	272,832,000	282,390,000
Other assets current	24,358,000	21,548,000
Total current assets	2,576,769,000	3,210,409,000
Property, plant and equipment, net	571,955,000	579,364,000
Intangible assets, net	61,036,000	78,246,000
Goodwill	532,251,000	532,251,000
Other assets noncurrent	61,843,000	51,291,000
TOTAL ASSETS	3,803,854,000	4,451,561,000
Current liabilities:
Accounts payable	86,798,000	92,572,000
Price adjustment and other revenue reserves	106,011,000	0
Income taxes payable	44,179,000	17,961,000
Accrued salary and related expenses	128,365,000	151,682,000
Accrued expenses	33,644,000	35,774,000
Short-term Debt	0	499,406,000
Total current liabilities	398,997,000	797,395,000
Long term debt	992,225,000	991,147,000
Income taxes payable	688,780,000	661,336,000
Other liabilities	61,105,000	70,743,000
Total liabilities	2,141,107,000	2,520,621,000
Commitments and contingencies (Note 11)
Stockholders' equity:
Common stock and capital in excess of par value	279,000	279,000
Retained earnings	1,672,938,000	1,945,646,000
Accumulated other comprehensive loss	(10,470,000)	(14,985,000)
Total stockholders' equity	1,662,747,000	1,930,940,000
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY	3,803,854,000	4,451,561,000
Intellectual Property [Member]
Finite-Lived Intangible Assets, Gross	$ 488,846,000	$ 485,465,000

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets Parenthetical - USD ($) $ in Thousands	Mar. 30, 2019	Jun. 30, 2018
Statement of Financial Position [Abstract]
Allowance for Doubtful Accounts Receivable, Current	$ 608	$ 140,296

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018
Interest Expense	$ 9,300	$ 12,400	$ 33,900	$ 37,600
Interest Expense, Debt	8,900	12,400	32,500	37,100
Allocated Share-based Compensation Expense	22,820	20,605	64,973	58,932
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense	1,946	2,053	6,214	6,830
Allocated Share-based Compensation Expense, Net of Tax	20,874	18,552	58,759	52,102
Revenue from Contract with Customer, Excluding Assessed Tax	542,383	648,599	1,757,784	1,846,913
Net revenues	542,383	648,599	1,757,784	1,846,913
Cost of goods sold	201,552	224,653	613,669	639,460
Gross margin	340,831	423,946	1,144,115	1,207,453
Operating expenses:
Research and development	107,075	114,390	330,086	338,886
Selling, general and administrative	74,116	81,304	233,487	240,308
Intangible asset amortization	756	876	2,285	3,623
Impairment of long-lived assets	0	0	753	892
Severance and Restructuring Charges	1,744	2,272	3,917	14,227
Other operating expenses (income), net	0	266	60	(1,535)
Total operating expenses	183,691	199,108	570,588	596,401
Operating income	157,140	224,838	573,527	611,052
Interest and other income (expense), net	3,318	(2,534)	3,244	(9,868)
Income before provision for income taxes	160,458	222,304	576,771	601,184
Income tax provision (benefit)	29,845	28,677	116,843	328,038
Net income	$ 130,613	$ 193,627	$ 459,928	$ 273,146
Earnings per share:
Basic	$ 0.48	$ 0.69	$ 1.67	$ 0.97
Diluted	$ 0.47	$ 0.68	$ 1.64	$ 0.95
Shares used in the calculation of earnings per share:
Basic	273,221	280,850	275,831	281,525
Diluted	276,610	285,881	279,680	286,221
Employee Stock Option [Member]
Allocated Share-based Compensation Expense	$ 77	$ 99	$ 233	$ 1,339
Restricted Stock Units (RSUs) [Member]
Allocated Share-based Compensation Expense	19,534	17,946
ESP Plan [Member]
Allocated Share-based Compensation Expense	3,209	2,560	7,760	6,594
Restricted Stock [Member]
Allocated Share-based Compensation Expense			56,980	50,999
Cost of Sales [Member]
Allocated Share-based Compensation Expense	2,613	2,575	7,281	7,461
Cost of Sales [Member] | Employee Stock Option [Member]
Allocated Share-based Compensation Expense	8	35	28	196
Cost of Sales [Member] | Restricted Stock Units (RSUs) [Member]
Allocated Share-based Compensation Expense	1,951	2,003	5,597	5,783
Cost of Sales [Member] | ESP Plan [Member]
Allocated Share-based Compensation Expense	654	537	1,656	1,482
Research and Development Expense [Member]
Allocated Share-based Compensation Expense	11,062	10,077	30,758	28,061
Research and Development Expense [Member] | Employee Stock Option [Member]
Allocated Share-based Compensation Expense	5	13	27	507
Research and Development Expense [Member] | Restricted Stock Units (RSUs) [Member]
Allocated Share-based Compensation Expense	9,399	8,725	26,783	24,212
Research and Development Expense [Member] | ESP Plan [Member]
Allocated Share-based Compensation Expense	$ 1,658	$ 1,339	3,948	3,342
Selling, General and Administrative Expenses [Member]
Allocated Share-based Compensation Expense			26,934	23,410
Selling, General and Administrative Expenses [Member] | Employee Stock Option [Member]
Allocated Share-based Compensation Expense			178	636
Selling, General and Administrative Expenses [Member] | Restricted Stock Units (RSUs) [Member]
Allocated Share-based Compensation Expense			24,600	21,004
Selling, General and Administrative Expenses [Member] | ESP Plan [Member]
Allocated Share-based Compensation Expense			$ 2,156	$ 1,770

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018
Statements of Income and Comprehensive Income [Abstract]
Net income	$ 130,613	$ 193,627	$ 459,928	$ 273,146
Change in net unrealized gains and losses on available-for-sale securities, net of tax benefit (expense) of $97, $274, ($131), and $274, respectively	1,139	(1,213)	3,116	(3,433)
Change in net unrealized gains and losses on cash flow hedges, net of tax benefit (expense) of $69, $6, $(241), and $(45), respectively	(351)	(217)	1,167	133
Change in net unrealized gains and losses on post-retirement benefits, net of tax benefit (expense) of $(23), $(4), $(60), and $(168), respectively	78	18	232	(14)
Other comprehensive income (loss), net	866	(1,412)	4,515	(3,314)
Total comprehensive income	131,479	192,215	464,443	269,832
Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, Tax	97	274	(131)	274
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax	69	6	(241)	(45)
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax	$ (23)	$ (4)	$ (60)	$ (168)

Condensed Consolidated Statem_3

Condensed Consolidated Statement of Shareholders' Equity Statement - USD ($) shares in Thousands		Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]
Common Stock, Shares, Outstanding		282,912
Stockholders' Equity, Other		$ 1,985,698,000	$ 283,000		$ 1,997,207,000	$ (11,792,000)
Stockholders' Equity, Other		$ 1,930,940,000			1,945,646,000	(14,985,000)
Common Stock, Shares, Outstanding			281,438
Common Stock, Shares, Outstanding		278,664
Stockholders' Equity, Other		$ 1,755,414,000	$ 279,000		1,766,471,000	(11,336,000)
Stockholders' Equity, Other		1,662,747,000	$ 279,000		1,672,938,000	(10,470,000)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest		459,928,000			459,928,000
Other Comprehensive Income (Loss), Net of Tax		4,515,000
Shares of common stock repurchased			(8,032)
Value of common stock repurchased		(437,047,000)	$ 0	$ 82,155,000	354,892,000	0
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures			980
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures		(23,026,000)	$ 0	(23,026,000)	0	0
Stock Issued During Period, Shares, Other			699
Stock Issued During Period, Value, Stock Options Exercised		18,986,000	$ 0	18,986,000	0	0
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition		65,035,000	$ 0	65,035,000	0	0
Modification Of Liability Instruments To Equity	[1]			3,471,000
Stock Issued During Period, Shares, Employee Stock Purchase Plans			384
Stock Issued During Period, Value, Employee Stock Ownership Plan			$ 0
Stock Issued During Period, Value, Employee Stock Purchase Plan		17,689,000		17,689,000	0	0
Dividends		1.38
Dividends, Common Stock, Cash		$ (380,231,000)	$ 0	$ 0	(380,231,000)	$ 0
Common Stock, Shares, Outstanding			274,326
Common Stock, Shares, Outstanding		272,695
Cumulative Effect of New Accounting Principle in Period of Adoption		$ 2,487,000			$ 2,487,000
[1]	(1) In December 2018, $3.5 million was reclassified from accrued salaries to additional paid-in capital due to a settlement agreement relating to the expiration of stock options.

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Mar. 30, 2019	Mar. 31, 2018
Cash flows from operating activities:
Net income	$ 459,928	$ 273,146
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation	64,973	58,932
Depreciation and amortization	85,176	109,768
Deferred taxes	(12,161)	6,257
Gain (Loss) on Disposition of Property Plant Equipment	3,324	572
Impairment of investments in privately-held companies	265	850
Other adjustments	0	42
Changes in assets and liabilities:
Accounts receivable	5,475	(60,194)
Inventories	9,620	(23,326)
Other current assets	(3,026)	31,703
Accounts payable	(10,971)	3,429
Income taxes payable	53,662	280,664
Deferred income on shipments to distributors	0	(14,974)
Accrued salary and related expenses	(19,845)	1,826
All other accrued liabilities	1,953	4,110
Net cash provided by (used in) operating activities	638,373	672,805
Cash flows from investing activities:
Purchases of property, plant and equipment	(52,170)	(53,664)
Proceeds from sale of property, plant, and equipment	34	5,761
Proceeds from sale of available-for-sale securities	30,192	100,004
Proceeds from maturity of available-for-sale securities	1,027,083	422,500
Payment in connection with business acquisition, net of cash acquired	(2,949)	(57,773)
Purchases of available-for-sale securities	(214,587)	(1,122,291)
Purchases of privately-held companies' securities	(1,676)	(3,356)
Payments for (Proceeds from) Other Investing Activities	(540)	0
Net cash provided by (used in) investing activities	785,387	(708,819)
Cash flows from financing activities:
Repayment of debt	(500,000)	0
Contingent consideration paid	(9,052)	0
Payments of Stock Issuance Costs	(23,026)	(21,162)
Proceeds from stock options exercised	18,986	26,383
Issuance of common stock under employee stock purchase program	17,689	14,975
Repurchase of common stock	(437,047)	(279,944)
Payments of Dividends	(380,231)	(320,766)
Net cash provided by (used in) financing activities	(1,312,681)	(580,514)
Net increase (decrease) in cash and cash equivalents	111,079	(616,528)
Cash and cash equivalents:
Beginning of period	1,543,484	2,246,121
End of period	1,654,563	1,629,593
Supplemental disclosures of cash flow information:
Cash paid (refunded), net during the period for income taxes	74,385	17,281
Cash paid for interest	31,751	31,750
Noncash investing and financing activities:
Accounts payable related to property, plant, and equipment purchases	$ 15,252	$ 6,798

Basis of Presentation

Basis of Presentation	9 Months Ended
	Mar. 30, 2019
Basis of Presentation [Abstract]
Basis of Presentation [Text Block]	BASIS OF PRESENTATION The accompanying unaudited condensed consolidated financial statements of Maxim Integrated Products, Inc. and all of its majority-owned subsidiaries (collectively, the “Company” or “Maxim Integrated”) included herein have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with generally accepted accounting principles of the United States of America (“GAAP”) have been condensed or omitted pursuant to applicable rules and regulations. In the opinion of management, all adjustments of a normal recurring nature which were considered necessary for fair statement have been included. The year-end condensed consolidated balance sheet data were derived from audited consolidated financial statements but do not include all disclosures required by GAAP. The results of operations for the nine months ended March 30, 2019 are not necessarily indicative of the results to be expected for the entire year. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2018 . The Company has a 52-to-53-week fiscal year that ends on the last Saturday in June. Accordingly, every fifth or sixth fiscal year will be a 53-week fiscal year. Fiscal year 2018 was a 53-week fiscal year and fiscal year 2019 is a 52-week fiscal year. The second quarter of fiscal year 2018 was a 14-week quarter and the second quarter of fiscal year 2019 was a 13-week quarter.

Recently Issued Accounting Pron

Recently Issued Accounting Pronouncements	9 Months Ended
	Mar. 30, 2019
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
Recently Issued Accounting Pronouncements [Text Block]	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Recently Issued Accounting Pronouncements (i) New Accounting Updates Recently Adopted In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") 2014-09, Revenue from Contracts with Customers (Topic 606) . This standard provides a single set of guidelines for revenue recognition to be used across all industries. Under the new standard, revenue is recognized when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, the new standard requires reporting companies to disclose the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. On July 1, 2018, the Company adopted Topic 606 and related amendments (ASU 2015-14, Deferral of the Effective Date ; ASU 2016-08, Principal versus Agent Considerations ; ASU 2016-10, Identifying Performance Obligations and Licensing , ASU 2016-12, Narrow-Scope Improvements and Practical Expedients and ASU 2016-20, Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customers ) using the modified retrospective method applied to all contracts that are not completed at the date of initial application (i.e., July 1, 2018). Results for reporting periods beginning after July 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with historic accounting standards under Topic 605. There was no impact on the opening retained earnings as of July 1, 2018 due to the adoption of Topic 606. However, in conjunction with the adoption of the new standard, the Company recorded a reclassification of accrued revenue reserves for price adjustments and other revenue reserves from accounts receivable, net to price adjustment and other revenue reserves within current liabilities. The cumulative effect of the changes to the condensed consolidated balance sheet from the adoption of Topic 606 was as follows (in thousands): As of June 30, 2018 Effect of Adoption of Topic 606 As of July 1, 2018 Accounts receivable, net $ 280,072 $ 141,652 $ 421,724 Price adjustment and other revenue reserves — 141,652 141,652 Balance Sheet Reclassification Under Topic 605, the gross amount of accrued revenue reserves for price adjustments and other revenue reserves of $141.7 million was included within accounts receivable, net as of June 30, 2018. Subsequent to the adoption of Topic 606, such balances are presented on a gross basis as accrued price adjustments and other revenue reserves of $141.7 million , which is presented in the price adjustment and other revenue reserves balance sheet caption. The adoption of Topic 606 has no impact on the total cash flows from operating, investing, or financing activities on the Condensed Consolidated Statements of Cash Flows. The following table summarizes the impacts of adopting Topic 606 on the Company’s Condensed Consolidated Balance Sheet as of March 30, 2019 (in thousands): As Reported If Reported Under Topic 605 Effect of Adoption of Topic 606 Accounts receivable, net $ 381,152 $ 275,141 $ 106,011 Price adjustment and other revenue reserves 106,011 — 106,011 Practical Expedients and Elections • The Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which the Company recognizes revenue at the amount to which it has the right to invoice for services performed. • The Company has elected to account for shipping and handling costs as fulfillment costs after the customer obtains control of the goods. • The Company has elected to exclude sales, use, value added, and some excise taxes, if applicable, from the measurement of the transaction price. Updated Revenue Recognition Policy The Company recognizes revenue for sales to direct customers and distribution customers ("distributors") when a customer obtains control of promised goods or services in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services. The transaction price is calculated as selling price net of variable considerations, such as distributor price adjustments. In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to which it is expected to be entitled. The transaction price does not include amounts collected on behalf of another party, such as sales taxes or value added tax. The Company elected the practical expedient to not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed. The Company estimates returns for sales to direct customers and distributors based on historical return rates applied against current period gross revenue. Specific customer returns and allowances are considered within this estimate. Accounts receivable from direct customers and distributors are recognized and inventory is relieved upon shipment as title to inventories generally transfers upon shipment, at which point the Company has a legally enforceable right to collection under normal terms. Accounts receivable related to consigned inventory is recognized when the customer takes title to such inventory from its consigned location, at which point inventory is relieved, title transfers, and the Company has a legally enforceable right to collection under the terms of the agreement with the related customers. Customers are generally required to pay for products and services within the Company’s standard terms, which is net 30 days from the date of invoice. The Company does not have any significant financing components greater than one year. The Company estimates potential future returns and sales allowances related to current period product revenue. Management analyzes historical returns, changes in customer demand and acceptance of products when evaluating the adequacy of returns and sales allowances. Estimates made may differ from actual returns and sales allowances. These differences may materially impact reported revenue and amounts ultimately collected on accounts receivable. Historically, such differences have not been material. Distributor price adjustments are estimated based on the Company's historical experience rates and also considering economic conditions and contractual terms. To date, actual distributor claims activity has been materially consistent with the estimates that the Company has made based on its historical rates. The Company's revenue arrangements do not contain significant financing components. Revenue is recognized over a period of time when it is assessed that performance obligations are satisfied over a period rather than at a point in time. When any of the following criteria is fulfilled, revenue is recognized over a period of time: (a) The customer simultaneously receives and consumes the benefits provided by the performance completed. (b) Performance creates or enhances an asset (for example, work in process) that the customer controls as the asset is created or enhanced. (c) Performance does not create an asset with an alternative use, and has an enforceable right to payment for performance completed to date. In January 2016, the FASB issued ASU 2016-01, Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities, with further classifications made recently with the issuance of ASU 2018-03 and ASU 2018-04, which provides guidance for the recognition, measurement, presentation, and disclosure of financial assets and liabilities. The application of this ASU was made by the means of a cumulative-effect adjustment to the balance sheet for the equity securities that qualify for the practical expedient to estimate fair value using the net asset value per share. The amendments related to equity securities without readily determinable fair values (including disclosure requirements) is being applied prospectively to equity investments that exist as of the date of adoption. The Company adopted ASU 2016-01 in the first quarter of fiscal year 2019. As a result of this adoption, the Company recognized an increase of $2.5 million , net of tax, in retained earnings at the beginning of fiscal year 2019. In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory . ASU 2016-16 requires that entities recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs instead of when the asset is sold. The Company adopted ASU 2016-16 in the first quarter of fiscal year 2019. The adoption of this guidance did not have an impact on the Company's consolidated financial statements. In March 2017, the FASB issued ASU 2017-07, Compensation - Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost , which requires employers that offer or maintain defined benefit plans to disaggregate the service component from the other components of net benefit cost and provides guidance on presentation of the service component and the other components of net benefit cost in the statement of operations. The application of ASU 2017-07 requires retrospective basis for all periods presented. The Company adopted ASU 2017-07 in the first quarter of fiscal year 2019. The adoption of this guidance did not have a material impact on the Company's consolidated financial statements. In May 2017, the FASB issued ASU 2017-09, Compensation - Stock Compensation (Topic 718): Scope of Modification Accounting. The amendments in this standard provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. Unless the changes in terms or conditions meet all three criteria outlined in the guidance, modification accounting should be applied. The three criteria relate to changes in the terms and conditions that affect the fair value, vesting conditions, or classification of a share-based payment award. The guidance is required to be applied prospectively to an award modified on or after the adoption date. The Company adopted ASU 2017-09 in the first quarter of fiscal year 2019. The adoption of this guidance did not have an impact on the Company's consolidated financial statements. In February 2018, the FASB issued ASU 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income . This standard provides guidance about the reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act. The Company adopted ASU 2018-02 in the first quarter of fiscal year 2019. There was no material change to the Company's consolidated financial statements as a result of this adoption. In June 2018, the FASB issued ASU 2018-07, Compensation - Stock Compensation (Topic 718): Improvements to Non-employee Share-Based Payment Accounting . This ASU largely aligns the accounting for share-based payment awards to employees and non-employees. Under the new guidance, both sets of awards, for employees and non-employees, will essentially follow the same model, with small discrepancies related to the term assumption when valuing non-employee awards. The Company adopted ASU 2018-07 in the first quarter of fiscal year 2019. The adoption of this guidance did not have an impact on the Company's consolidated financial statements. SEC Disclosure Update and Simplification. In August 2018, the SEC adopted a final rule under SEC Release No. 33-10532, Disclosure Update and Simplification, which amends certain disclosure requirements that were redundant and outdated. The rule also requires registrants to include in their interim financial statements a reconciliation of changes in stockholders' equity in the notes or as a separate statement. The final rule was effective on November 5, 2018. The Company has adopted the final rule as of December 29, 2018, and has included a reconciliation of the changes in stockholders' equity in this Form 10-Q. (ii) Recent Accounting Updates Not Yet Effective In February 2016, the FASB issued ASU 2016-02, Leases and subsequent amendments to the initial update: ASU 2017-13, ASU 2018-01, ASU 2018-11, ASU 2018-20 and ASU 2019-01 (collectively, Topic 842 ), which supersede the lease accounting requirements in Topic 840. Topic 842 requires a dual approach for lessee accounting under which a lessee would account for leases as finance leases or operating leases. Both finance leases and operating leases will result in the lessee recognizing a right-of-use asset and a corresponding lease liability. For finance leases, the lessee would recognize interest expense and amortization of the right-of-use asset, and for operating leases, the lessee would recognize a straight-line total lease expense. The guidance also requires qualitative and specific quantitative disclosures to supplement the amounts recorded in the financial statements so that users can understand more about the nature of an entity’s leasing activities, including significant judgments and changes in judgments. This guidance is effective beginning in the first quarter of fiscal year 2020 on a modified retrospective approach. The Company is currently evaluating the potential impact of this standard on its consolidated financial statements and expects that there will be a material increase in assets and liabilities on the Consolidated Balance Sheets at adoption due to the recognition of right-of-use assets and related lease liabilities. Upon adoption, the Company expects that its financial statement disclosures will be expanded to present additional details of its leasing arrangements. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement, which improves disclosures by removing, modifying and adding disclosure requirements related to fair value measurements. The update highlights adjustments in disclosures for changes in the fair value of Level 1, Level 2, and Level 3 instruments. This guidance is effective beginning in the first quarter of fiscal year 2021, with early adoption permitted. The Company does not believe that this update will have a material impact on its consolidated financial statements.

Balance Sheet Components

Balance Sheet Components	9 Months Ended
	Mar. 30, 2019
Balance Sheet Related Disclosures [Abstract]
Balance Sheet Components [Text Block]	BALANCE SHEET COMPONENTS Inventories consist of: March 30, June 30, Inventories: (in thousands) Raw materials $ 18,799 $ 16,251 Work-in-process 172,020 173,859 Finished goods 82,013 92,280 $ 272,832 $ 282,390 Property, plant and equipment, net consists of: March 30, June 30, Property, plant and equipment, net: (in thousands) Land $ 17,731 $ 17,731 Buildings and building improvements 258,642 254,733 Machinery, equipment and software 1,358,892 1,309,487 1,635,265 1,581,951 Less: accumulated depreciation (1,063,310 ) (1,002,587 ) $ 571,955 $ 579,364 Accrued salary and related expenses consist of: March 30, June 30, Accrued salary and related expenses: (in thousands) Accrued vacation $ 28,831 $ 30,695 Accrued bonus 56,187 92,288 Accrued salaries 13,711 8,210 ESPP withholding 15,634 5,158 Accrued fringe benefits 8,075 4,752 Other 5,927 10,579 $ 128,365 $ 151,682

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Mar. 30, 2019
Fair Value Disclosures [Abstract]
Fair Value Measurements [Text Block]	FAIR VALUE MEASUREMENTS The FASB established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. This hierarchy requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Three levels of inputs that may be used to measure fair value are as follows: Level 1 - Quoted (unadjusted) prices in active markets for identical assets or liabilities. The Company’s Level 1 assets consist of money market funds. Level 2 - Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability. The Company’s Level 2 assets and liabilities consist of U.S. Treasury securities, agency securities, corporate debt securities, certificates of deposit, commercial paper and foreign currency forward contracts that are valued using quoted market prices or are determined using a yield curve model based on current market rates. Level 3 - Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. The Company's Level 3 assets and liabilities consist of acquisition related contingent consideration liabilities. Assets and liabilities measured at fair value on a recurring basis were as follows: As of March 30, 2019 As of June 30, 2018 Fair Value Measurements Using Total Fair Value Measurements Using Total Level 1 Level 2 Level 3 Level 1 Level 2 Level 3 (in thousands) Assets Cash and cash equivalents Agency securities $ — $ — $ — $ — $ — $ 13,946 $ — $ 13,946 Certificates of deposit — — — — — 6,000 — 6,000 Commercial paper — — — — — 45,063 — 45,063 Corporate debt securities — — — — — 3,819 — 3,819 Money market funds 195,805 — — 195,805 98,467 — — 98,467 U.S. Treasury securities — — — — — 30,988 — 30,988 Short term investments Certificates of deposit — 5,000 — 5,000 — 52,428 — 52,428 Commercial paper — 2,999 — 2,999 — 64,354 — 64,354 Corporate debt securities — 185,994 — 185,994 — 367,765 — 367,765 U.S. Treasury securities — 49,871 — 49,871 — 598,368 — 598,368 Other current assets Foreign currency forward contracts — 230 — 230 — 235 — 235 Total assets $ 195,805 $ 244,094 $ — $ 439,899 $ 98,467 $ 1,182,966 $ — $ 1,281,433 Liabilities Accrued expenses Foreign currency forward contracts $ — $ 496 $ — $ 496 $ — $ 1,845 $ — $ 1,845 Contingent consideration — — 9,052 9,052 — — 8,000 8,000 Other liabilities Contingent consideration — — — — — — 8,000 8,000 Total Liabilities $ — $ 496 $ 9,052 $ 9,548 $ — $ 1,845 $ 16,000 $ 17,845 During the nine months ended March 30, 2019 and the year ended June 30, 2018 , there were no transfers in or out of Level 3 from other levels in the fair value hierarchy. There were no assets or liabilities measured at fair value on a non-recurring basis as of March 30, 2019 and June 30, 2018 other than impairments of long-lived assets. The Company uses various inputs to evaluate investments in privately held companies, including valuations of recent financing events as well as other relevant information regarding the performance of the issuer. There were no material impairments of long-lived assets in any of the periods presented.

Financial Instruments

Financial Instruments	9 Months Ended
	Mar. 30, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Financial Instruments [Text Block]	FINANCIAL INSTRUMENTS Short-term investments Fair values were as follows: March 30, 2019 June 30, 2018 Amortized Cost Gross Unrealized Gain Gross Unrealized Loss Estimated Fair Value Amortized Cost Gross Unrealized Gain Gross Unrealized Loss Estimated Fair Value (in thousands) Available-for-sale investments Certificates of deposit $ 5,000 $ — $ — $ 5,000 $ 52,429 $ — $ (1 ) $ 52,428 Commercial paper 2,999 — — 2,999 64,354 — — 64,354 Corporate debt securities 186,446 21 (473 ) 185,994 369,734 39 (2,008 ) 367,765 U.S. Treasury securities 49,973 — (102 ) 49,871 600,068 10 (1,710 ) 598,368 Total available-for-sale investments $ 244,418 $ 21 $ (575 ) $ 243,864 $ 1,086,585 $ 49 $ (3,719 ) $ 1,082,915 In the three and nine months ended March 30, 2019 and June 30, 2018 , the Company did not recognize any impairment charges on short-term investments. All available-for-sale investments have maturity dates between April 1, 2019 and March 12, 2021. The Company invests in various financial instruments including U.S. Treasury securities, corporate debt securities, commercial paper, and certificates of deposit which include instruments issued or managed by industrial, financial, and utility institutions and U.S. Treasury securities which include U.S. government Treasury bills and Treasury notes. Derivative instruments and hedging activities The Company incurs expenditures denominated in non-U.S. currencies, primarily the Philippine Peso and the Thai Baht associated with the Company's manufacturing activities in the Philippines and Thailand, respectively, and the European Euro, Indian Rupee, Japanese Yen, Taiwan New Dollar, South Korean Won, Chinese Yuan and Canadian Dollar, for sales offices and research and development activities undertaken outside of the U.S. The Company has established a program that primarily utilizes foreign currency forward contracts to offset the risks associated with the effects of certain foreign currency exposures. The Company does not use these foreign currency forward contracts for trading purposes. Derivatives designated as cash flow hedging instruments The Company designates certain forward contracts as hedging instruments pursuant to Accounting Standards Codification (“ASC”) 815, Derivatives and Hedging (“ASC 815”). As of March 30, 2019 and June 30, 2018 , the notional amounts of the forward contracts the Company held to purchase international currencies were $44.4 million and $49.7 million , respectively, and the notional amounts of forward contracts the Company held to sell international currencies were $0 and $1.2 million , respectively. Derivatives not designated as hedging instruments As of March 30, 2019 and June 30, 2018 , the notional amounts of the forward contracts the Company held to purchase international currencies were $19.9 million and $21.1 million , respectively, and the notional amounts of forward contracts the Company held to sell international currencies were $21.9 million and $21.3 million , respectively. The Company's foreign currency forward contract gains or losses included in the Condensed Consolidated Statements of Income were not material for the three and nine months ended March 30, 2019 and March 31, 2018 . Effect of hedge accounting on the Condensed Consolidated Statements of Income The following tables summarize the gains (losses) from hedging activities recognized in the Company's Condensed Consolidated Statements of Income: Three Months Ended Nine Months Ended March 30, 2019 March 30, 2019 Net Revenue Cost of Goods Sold Operating Expenses Net Revenue Cost of Goods Sold Operating Expenses (in thousands) Income and expenses line items in which the effects of cash flow hedges are recorded $ 542,383 $ 201,552 $ 183,691 $ 1,757,784 $ 613,669 $ 570,588 Gain (loss) on cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from accumulated other comprehensive income into income $ 6 $ 261 $ (79 ) $ 50 $ (335 ) $ (1,906 ) Three Months Ended Nine Months Ended March 31, 2018 March 31, 2018 Net Revenue Cost of Goods Sold Operating Expenses Net Revenue Cost of Goods Sold Operating Expenses (in thousands) Income and expenses line items in which the effects of cash flow hedges are recorded $ 648,599 $ 224,653 $ 199,108 $ 1,846,913 $ 639,460 $ 596,401 Gain (loss) on cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from accumulated other comprehensive income into income $ (11 ) $ 165 $ 356 $ (64 ) $ 116 $ 1,781 Outstanding debt obligations The following table summarizes the Company’s outstanding debt obligations: March 30, 2019 June 30, 2018 (in thousands) 3.45% fixed rate notes due June 2027 $ 500,000 $ 500,000 2.5% fixed rate notes due November 2018 — 500,000 3.375% fixed rate notes due March 2023 500,000 500,000 Total outstanding debt 1,000,000 1,500,000 Less: Current portion (included in "Current portion of debt") — (499,406 ) Less: Reduction for unamortized discount and debt issuance costs (7,775 ) (9,447 ) Total long-term debt $ 992,225 $ 991,147 On June 15, 2017, the Company completed a public offering of $500 million aggregate principal amount of the Company's 3.45% senior unsecured and unsubordinated notes due in June 2027 (“2027 Notes”), with an effective interest rate of 3.5% . Interest on the 2027 Notes is payable semi-annually in arrears on June 15 and December 15 of each year, commencing on December 15, 2017. The net proceeds of this offering were approximately $495.2 million , after issuing at a discount and deducting paid expenses. On November 21, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 2.5% coupon senior unsecured and unsubordinated notes due in November 2018 (“2018 Notes”), with an effective interest rate of 2.6%. Interest on the 2018 Notes is payable semi-annually in arrears on May 15 and November 15 of each year, commencing on May 15, 2014. The net proceeds of this offering were approximately $494.5 million , after issuing at a discount and deducting paid expenses. In November of 2018, the Company repaid the entire $500 million in principal and any outstanding interest, related to these outstanding notes. On March 18, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 3.375% senior unsecured and unsubordinated notes due in March 2023 (“2023 Notes”), with an effective interest rate of 3.5% . Interest on the 2023 Notes is payable semi-annually in arrears on March 15 and September 15 of each year. The net proceeds of this offering were approximately $490.0 million , after issuing at a discount and deducting paid expenses. The debt indentures that govern the 2027 Notes and the 2023 Notes include covenants that limit the Company's ability to grant liens on its facilities and to enter into sale and leaseback transactions, which could limit the Company's ability to secure additional debt funding in the future. In circumstances involving a change of control of the Company followed by a downgrade of the rating of the 2027 Notes or the 2023 Notes, the Company would be required to make an offer to repurchase the affected notes at a purchase price equal to 101% of the aggregate principal amount of such notes, plus accrued and unpaid interest. The Company accounts for all the notes above based on their amortized cost. The discount and expenses are being amortized to Interest and other income (expense), net in the Condensed Consolidated Statements of Income over the life of the notes. The interest expense is recorded in Interest and other income (expense), net in the Condensed Consolidated Statements of Income. Amortized discount and expenses, as well as interest expense associated with the notes, were $8.9 million and $12.4 million during the three months ended March 30, 2019 and March 31, 2018 , respectively. Amortized discount and expenses, as well as interest expense associated with the notes, were $32.5 million and $37.1 million during the nine months ended March 30, 2019 and March 31, 2018 , respectively. The estimated fair value of the Company’s outstanding debt obligations was approximately $985 million as of March 30, 2019 . The estimated fair value of the debt is based primarily on observable market inputs and is a Level 2 measurement. The Company recorded interest expense of $9.3 million and $12.4 million during the three months ended March 30, 2019 , and March 31, 2018 , respectively. The Company recorded interest expense of $33.9 million and $37.6 million during the nine months ended March 30, 2019 and March 31, 2018 , respectively. Other Financial Instruments For the balance of the Company’s financial instruments, cash equivalents, accounts receivable, accounts payable and other accrued liabilities, the carrying amounts approximate fair value due to their short maturities.

Stock-Based Compensation

Stock-Based Compensation	9 Months Ended
	Mar. 30, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock-Based Compensation [Text Block]	STOCK-BASED COMPENSATION At March 30, 2019 , the Company had one stock incentive plan, the Company's 1996 Stock Incentive Plan (the “1996 Plan”) and one employee stock purchase plan, the 2008 Employee Stock Purchase Plan (the “2008 ESPP”). The 1996 Plan was adopted by the Board of Directors to provide the grant of incentive stock options, non-statutory stock options, restricted stock units (“RSUs”), and market stock units (“MSUs”) to employees, directors, and consultants. Pursuant to the 1996 Plan, the exercise price for incentive stock options and non-statutory stock options is determined to be the fair market value of the underlying shares on the date of grant. Options typically vest ratably over a four-year period measured from the date of grant. Options generally expire no later than seven years after the date of grant, subject to earlier termination upon an optionee's cessation of employment or service. RSUs granted to employees typically vest ratably over a four-year period and are converted into shares of the Company's common stock upon vesting, subject to the employee's continued service to the Company over that period. RSUs granted after August 2017 will continue to vest post-employment at the Company for certain individuals satisfying specific eligibility requirements. MSUs granted to employees typically vest over a four-year cliff period and are converted into shares of the Company's common stock upon vesting, subject to the employee's continued service to the Company over that period. The number of shares that are released at the end of the performance period can range from zero to a maximum cap depending on the Company's performance. MSUs granted after August 2017 will continue to vest post-employment at the Company for certain individuals satisfying specific eligibility requirements. The following tables show total stock-based compensation expense by type of award, and the resulting tax effect, included in the Condensed Consolidated Statements of Income for the three and nine months ended March 30, 2019 and March 31, 2018 , respectively: Three Months Ended March 30, 2019 March 31, 2018 Stock Options Restricted Stock Units Employee Stock Purchase Plan Total Stock Options Restricted Stock Units Employee Stock Purchase Plan Total (in thousands) Cost of goods sold $ 8 $ 1,951 $ 654 $ 2,613 $ 35 $ 2,003 $ 537 $ 2,575 Research and development 5 9,399 1,658 11,062 13 8,725 1,339 10,077 Selling, general and administrative 64 8,184 897 9,145 51 7,218 684 7,953 Pre-tax stock-based compensation expense $ 77 $ 19,534 $ 3,209 $ 22,820 $ 99 $ 17,946 $ 2,560 $ 20,605 Less: income tax effect 1,946 2,053 Net stock-based compensation expense $ 20,874 $ 18,552 Nine Months Ended March 30, 2019 March 31, 2018 Stock Options Restricted Stock Units Employee Stock Purchase Plan Total Stock Options Restricted Stock Units Employee Stock Purchase Plan Total (in thousands) Cost of goods sold $ 28 $ 5,597 $ 1,656 $ 7,281 $ 196 $ 5,783 $ 1,482 $ 7,461 Research and development 27 26,783 3,948 30,758 507 24,212 3,342 28,061 Selling, general and administrative 178 24,600 2,156 26,934 636 21,004 1,770 23,410 Pre-tax stock-based compensation expense $ 233 $ 56,980 $ 7,760 $ 64,973 $ 1,339 $ 50,999 $ 6,594 $ 58,932 Less: income tax effect 6,214 6,830 Net stock-based compensation expense $ 58,759 $ 52,102 The expenses included in the Condensed Consolidated Statements of Income for RSUs include expenses related to MSUs of $3.0 million and $2.2 million for the three months ended March 30, 2019 and March 31, 2018 , respectively, and $8.3 million and $5.8 million for the nine months ended March 30, 2019 and March 31, 2018 , respectively. Stock Options The fair value of options granted to employees under the 1996 Plan is estimated on the date of grant using the Black-Scholes option valuation model. There were no stock options granted in the three and nine months ended March 30, 2019 and March 31, 2018 . The following table summarizes outstanding, exercisable and vested and expected to vest stock options as of March 30, 2019 and related activity for the nine months ended March 30, 2019 : Number of Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (in Years) Aggregate Intrinsic Value (1) Balance at June 30, 2018 1,688,253 $ 27.72 Options Granted — — Options Exercised (699,416 ) 27.13 Options Cancelled (3,439 ) 28.08 Balance at March 30, 2019 985,398 $ 28.14 1.3 $ 25,692,173 Exercisable, March 30, 2019 985,398 $ 28.14 1.3 $ 25,692,173 Vested and expected to vest, March 30, 2019 985,398 $ 28.14 1.3 $ 25,692,173 (1) Aggregate intrinsic value represents the difference between the exercise price and the closing price per share of the Company’s common stock on March 29, 2019, the last business day preceding the fiscal quarter-end, multiplied by the number of options outstanding, exercisable or vested and expected to vest as of March 30, 2019. As of March 30, 2019 , there was no unrecognized stock compensation from unvested stock options. Restricted Stock Units and Other Awards The fair value of RSUs and other awards under the Company’s 1996 Plan is estimated using the value of the Company’s common stock on the date of grant, reduced by the present value of dividends expected to be paid on the Company’s common stock prior to vesting. The Company also estimates forfeitures at the time of grant and makes revisions to forfeitures on a quarterly basis. The weighted-average fair value of RSUs and other awards granted was $51.01 and $54.81 per share for the three months ended March 30, 2019 and March 31, 2018 , respectively, and $54.04 and $44.49 per share for the nine months ended March 30, 2019 and March 31, 2018 , respectively. The following table summarizes the outstanding and expected to vest RSUs and other awards as of March 30, 2019 and related activity during the nine months ended March 30, 2019 : Number of Shares Weighted Average Aggregate Intrinsic Value (1) Balance at June 30, 2018 5,524,432 Restricted stock units and other awards granted 1,614,379 Restricted stock units and other awards released (1,377,399 ) Restricted stock units and other awards cancelled (458,762 ) Balance at March 30, 2019 5,302,650 2.7 $ 287,456,657 Outstanding and expected to vest, March 30, 2019 4,439,502 2.7 $ 240,665,404 (1) Aggregate intrinsic value for RSUs and other awards represents the closing price per share of the Company’s common stock on March 29, 2019, the last business day preceding the fiscal quarter-end, multiplied by the number of RSUs outstanding or expected to vest as of March 30, 2019. The Company withheld shares totaling $23.0 million in value as a result of employee withholding taxes based on the value of RSUs on vesting date for the nine months ended March 30, 2019 . Total payments for employees’ tax obligations to taxing authorities are reflected as financing activities within the Condensed Consolidated Statements of Cash Flows. As of March 30, 2019 , there was $162.6 million of unrecognized compensation expense related to 5.3 million unvested RSUs and other awards, which is expected to be recognized over a weighted average period of approximately 2.7 years . Market Stock Units (MSUs) The Company grants MSUs to senior members of management in lieu of granting stock options. For MSUs granted prior to September 2017, the performance metrics of this program are based on relative performance of the Company’s stock price as compared to the Semiconductor Exchange Traded Fund index SPDR S&P (the “XSD”). For MSUs granted in September 2017 and after, the performance metrics for this program are based on the total shareholder return ("TSR") of the Company relative to the TSR of the other companies included in the XSD. The fair value of MSUs is estimated using a Monte Carlo simulation model on the date of grant. The Company also estimates forfeitures at the time of grant and makes revisions to forfeitures on a quarterly basis. Compensation expense is recognized based on the initial valuation and is not subsequently adjusted as a result of the Company’s performance relative to that of the XSD or the TSR of the companies included in the XSD, as applicable. Vesting for MSUs is contingent upon both service and market conditions and has a four-year vesting cliff period. MSUs granted after August 2017 vest based upon annual performance and are subject to continued service through the end of the four-year period, but will continue to vest post-employment at the Company for certain individuals satisfying specific eligibility requirements. The weighted-average fair value of MSUs granted was $75.48 and $51.03 per share for the nine months ended March 30, 2019 and March 31, 2018 , respectively. The following table summarizes the number of MSUs outstanding and expected to vest as of March 30, 2019 and their activity during the nine months ended March 30, 2019 : Number of Shares Weighted Average Aggregate Intrinsic (1) Balance at June 30, 2018 1,079,064 Market stock units granted 247,804 Market stock units released (13,594 ) Market stock units cancelled (264,742 ) Balance at March 30, 2019 1,048,532 2.7 $ 56,840,920 Outstanding and expected to vest, March 30, 2019 976,524 2.7 $ 52,937,345 (1) Aggregate intrinsic value for MSUs represents the closing price per share of the Company’s common stock on March 29, 2019, the last business day preceding the fiscal quarter-end, multiplied by the number of MSUs outstanding or expected to vest as of March 30, 2019. As of March 30, 2019 , there was $31.3 million of unrecognized compensation expense related to 1.0 million unvested MSUs, which is expected to be recognized over a weighted average period of approximately 2.7 years . Employee Stock Purchase Plan Employees are granted rights to acquire common stock under the 2008 ESPP. The fair value of 2008 ESPP rights granted to employees has been estimated at the date of grant using the Black-Scholes option valuation model using the following assumptions for the offering periods outstanding: Three Months Ended Nine Months Ended March 30, 2019 March 31, 2018 March 30, 2019 March 31, 2018 Expected holding period (in years) 0.5 years 0.5 years 0.5 years 0.5 years Risk-free interest rate 2.4% - 2.6% 1.1% - 1.5% 1.6% - 2.6% 0.8% - 1.5% Expected stock price volatility 27.5 % - 28.9% 20.5% - 20.7% 19.6% - 32.7 % 19.1% - 24.7% Dividend yield 2.8% - 3.1% 3.0% - 3.1% 2.8% - 3.1% 3.0% - 3.4% As of March 30, 2019 , there was $5.3 million of unrecognized compensation expense related to the 2008 ESPP.

Earnings Per Share

Earnings Per Share	9 Months Ended
	Mar. 30, 2019
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	EARNINGS PER SHARE Basic earnings per share are computed using the weighted average number of shares of common stock outstanding during the period. For purposes of computing basic earnings per share, the weighted average number of outstanding shares of common stock excludes unvested RSUs and other awards as well as MSUs. Diluted earnings per share incorporates the incremental shares issuable upon the assumed exercise of stock options, assumed release of unvested RSUs and other awards as well as MSUs, and assumed issuance of common stock under the 2008 ESPP using the treasury stock method. The following table sets forth the computation of basic and diluted earnings per share: Three Months Ended Nine Months Ended March 30, March 31, March 30, March 31, (in thousands, except per share data) Numerator for basic earnings per share and diluted earnings per share Net income $ 130,613 $ 193,627 $ 459,928 $ 273,146 Denominator for basic earnings per share 273,221 280,850 275,831 281,525 Effect of dilutive securities: Stock options, ESPP, RSUs, and MSUs 3,389 5,031 3,849 4,696 Denominator for diluted earnings per share 276,610 285,881 279,680 286,221 Earnings per share Basic $ 0.48 $ 0.69 $ 1.67 $ 0.97 Diluted $ 0.47 $ 0.68 $ 1.64 $ 0.95 For the three months ended March 30, 2019 and March 31, 2018 , and the nine months ended March 30, 2019 and March 31, 2018 , no stock awards were determined to be anti-dilutive. Therefore, none were excluded from the calculation of diluted earnings per share.

Segment Information

Segment Information	9 Months Ended
	Mar. 30, 2019
Segment Reporting [Abstract]
Segment Information [Text Block]	SEGMENT INFORMATION The Company designs, develops, manufactures and markets a broad range of linear and mixed signal integrated circuits. All of the Company's products are designed through a centralized R&D function, manufactured using centralized manufacturing (internal and external), and sold through a centralized sales force and shared wholesale distributors. one operating segment and reportable segment. In accordance with ASC No. 280, Segment Reporting (“ASC 280” ) , the Company considers operating segments to be components of the Company’s business for which separate financial information is available that is evaluated regularly by the Company’s Chief Operating Decision Maker in deciding how to allocate resources and in assessing performance. The Chief Operating Decision Maker for the Company was assessed and determined to be the CEO. The CEO reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance. Accordingly, the Company has determined that it has a single operating and reportable segment. Enterprise-wide information is provided in accordance with ASC 280. Geographical revenue information is based on customers’ ship-to location. Long-lived assets consist of property, plant and equipment. Property, plant and equipment information is based on the physical location of the assets at the end of each fiscal year. Net revenues from unaffiliated customers by geographic region were as follows: Three Months Ended Nine Months Ended March 30, 2019 March 31, 2018 March 30, 2019 March 31, 2018 (in thousands) United States $ 63,970 $ 75,760 $ 200,944 $ 223,021 China 183,753 219,160 611,768 662,114 Rest of Asia 176,396 222,207 583,616 586,109 Europe 104,124 114,254 316,155 329,939 Rest of World 14,140 17,218 45,301 45,730 $ 542,383 $ 648,599 $ 1,757,784 $ 1,846,913 Net long-lived assets by geographic region were as follows: March 30, June 30, (in thousands) United States $ 359,743 $ 361,432 Philippines 110,214 120,657 Rest of World 101,998 97,275 $ 571,955 $ 579,364

Comprehensive Income Loss

Comprehensive Income Loss	9 Months Ended
	Mar. 30, 2019
Statement of Comprehensive Income [Abstract]
Comprehensive Income [Text Block]	COMPREHENSIVE INCOME (LOSS) The changes in accumulated other comprehensive income (loss) by component and related tax effects in the nine months ended March 30, 2019 and March 31, 2018 were as follows: (in thousands) Unrealized Gains and (Losses) on Intercompany Receivables Unrealized Gains and (Losses) on Post-Retirement Benefits Cumulative Translation Adjustment Unrealized Gains and (Losses) on Cash Flow Hedges Unrealized Gains and (Losses) on Available-For-Sale Securities Total June 30, 2018 $ (6,280 ) $ (2,516 ) $ (1,136 ) $ (1,383 ) $ (3,670 ) $ (14,985 ) Other comprehensive income (loss) before reclassifications — — — (783 ) 3,247 2,464 Amounts reclassified out of accumulated other comprehensive loss (income) — 292 — 2,191 — 2,483 Tax effects — (60 ) (241 ) (131 ) (432 ) Other comprehensive income, net — 232 — 1,167 3,116 4,515 March 30, 2019 $ (6,280 ) $ (2,284 ) $ (1,136 ) $ (216 ) $ (554 ) $ (10,470 ) (in thousands) Unrealized Gains and (Losses) on Intercompany Receivables Unrealized Gains and (Losses) on Post-Retirement Benefits Cumulative Translation Adjustment Unrealized Gains and (Losses) on Cash Flow Hedges Unrealized Gains and (Losses) on Available-For-Sale Securities Total June 24, 2017 $ (6,280 ) $ (1,258 ) $ (1,136 ) $ 18 $ (1,234 ) $ (9,890 ) Other comprehensive income (loss) before reclassifications — — — 2,012 (3,707 ) (1,695 ) Amounts reclassified out of accumulated other comprehensive loss (income) — 154 — (1,834 ) — (1,680 ) Tax effects — (168 ) — (45 ) 274 61 Other comprehensive income (loss), net — (14 ) — 133 (3,433 ) (3,314 ) March 31, 2018 $ (6,280 ) $ (1,272 ) $ (1,136 ) $ 151 $ (4,667 ) $ (13,204 )

Income Taxes

Income Taxes	9 Months Ended
	Mar. 30, 2019
Income Tax Disclosure [Abstract]
Income Taxes [Text Block]	INCOME TAXES In the three and nine months ended March 30, 2019 , the Company recorded an income tax provision of $29.8 million and $116.8 million , respectively, compared to $28.7 million and $328.0 million for the three and nine months ended March 31, 2018 , respectively. The Company’s effective tax rate for the three and nine months ended March 30, 2019 was 18.6% and 20.3% , respectively, compared to the 12.9% and 54.6% for the three and nine months ended March 31, 2018 , respectively. On December 22, 2017 legislation, commonly referred to as the Tax Cuts and Jobs Act (the “Act”), was enacted. The Act included a one-time tax on accumulated unremitted earnings of our foreign subsidiaries (“Transition Tax”). SEC Staff Accounting Bulletin No. 118 allowed the use of provisional amounts (reasonable estimates) if accounting for the income tax effects of the Act was not completed. Provisional amounts must be adjusted within a one-year measurement period from the enactment date of the Act. In the second quarter of fiscal year 2018, the Company recorded a discrete $236.9 million provisional Transition Tax charge. During the measurement period, the Company gathered information and analyzed available guidance to more precisely compute the amount of the Transition Tax. In the second quarter of fiscal year 2019 the Company completed this work and recorded a discrete $22.1 million measurement period adjustment for the Transition Tax, which increased the Company’s effective tax rate for the nine months ended March 30, 2019 by 3.8% . As of the end of the second quarter of fiscal year 2019, the accounting for income tax effects of the Act has been completed. The Act reduced the federal statutory tax rate from 35% to 21% , effective January 1, 2018, which resulted in a fiscal year 2018 federal statutory tax rate of 28.1% for the Company (average of a 35% rate for the first half of fiscal year 2018 and a 21% rate for the second half of fiscal year 2018). The Company’s federal statutory tax rate for fiscal year 2019 is 21% . In the second quarter of fiscal year 2018, the Company recorded a $13.7 million discrete charge to remeasure deferred tax assets and liabilities as of the enactment date of the Act to reflect the federal statutory tax rate reductions. The Act included Global Intangible Low-Taxed Income (“GILTI”) provisions, which first impact the Company in fiscal year 2019. The GILTI provisions effectively subject income earned by the Company’s foreign subsidiaries to current U.S. tax at a rate of 10.5%, less foreign tax credits. The Company has elected to treat tax generated by the GILTI provisions as a period expense. The Company’s federal statutory tax rate for fiscal year 2019 is 21% . The Company’s effective tax rate for the three months ended March 30, 2019 was lower than the statutory rate primarily due to earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, that were taxed at lower rates, partially offset by tax generated by the GILTI provisions, a $4.1 million discrete charge for differences between the Company's fiscal year 2018 tax returns and the tax provision originally recorded, and $5.7 million of discrete interest accruals for unrecognized tax benefits. The Company’s effective tax rate for the nine months ended March 30, 2019 was lower than the statutory rate primarily due to earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, that were taxed at lower rates, partially offset by $21.0 million of discrete charges for the Transition Tax, tax generated by the GILTI provisions, $15.1 million of discrete interest accruals for unrecognized tax benefits, and $4.8 million of discrete charges for differences between the Company's fiscal year 2018 tax returns and the tax provision originally recorded. The Company’s federal statutory tax rate for fiscal year 2018 was 28.1% . The Company’s effective tax rate for the three months ended March 31, 2018 , was lower than the statutory rate primarily due to earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, that were taxed at lower rates, and $4.6 million of discrete excess tax benefits generated by the settlement of share-based awards, partially offset by $5.1 million of discrete interest accruals for unrecognized tax benefits. The Company’s effective tax rate for the nine months ended March 31, 2018 was higher than the statutory rate primarily due to a $236.9 million discrete provisional charge for the Transition Tax, a $13.7 million discrete charge to remeasure deferred taxes as of the enactment date of the Act, and $13.1 million of discrete interest accruals for unrecognized tax benefits, partially offset by earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, that were taxed at lower rates and $8.3 million of discrete excess tax benefits generated by the settlement of share-based awards. The Company engages in continuous discussions and negotiations with tax authorities regarding tax matters in various jurisdictions. It is reasonably possible that gross unrecognized tax benefits, including accrued interest and penalties, could decrease up to $448 million within the next twelve months, primarily due to the completion of federal tax audits, including any administrative appeals. The $448 million primarily relates to matters involving federal taxation of cross-border transactions. The Company’s federal corporate income tax returns are audited on a recurring basis by the Internal Revenue Service (“IRS”). The IRS concluded its field examination of the Company’s federal corporate income tax returns for fiscal years 2009 through 2011 and issued an IRS Revenue Agent's Report in July 2016 that included proposed adjustments for transfer pricing issues related to cost sharing and buy-in license payments for the use of intangible property by one of the Company’s international subsidiaries. The Company disagreed with the proposed transfer pricing adjustments and related penalties, and in September 2016, the Company filed a protest to challenge the proposed adjustments and request a conference with the Appeals Office of the IRS. In May 2018, a preliminary understanding was reached with the IRS regarding the contested issues for the audit and post-audit years, which the Company expects may be finalized in fiscal year 2019 with the execution of a closing agreement. In June 2018, the Company made advance payments for audit and post-audit years tax of $140.7 million and interest of $37.4 million . These payments will reduce the accrual of interest on audit and post-audit years tax deficiencies that would be owed if the preliminary understanding is finalized. The Company’s reserves for unrecognized tax benefits are sufficient to cover the audit and post-audit years tax deficiencies that would be owed as a result of the preliminary understanding. In fiscal year 2017, the IRS commenced an audit of the Company’s federal corporate income tax returns for fiscal years 2012 through 2014, which is ongoing. In the first quarter of fiscal year 2019, the Company was notified that the IRS will commence an audit of the Company's federal corporate income tax returns for fiscal years 2015 through 2016.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Mar. 30, 2019
Product Warranties Disclosures [Abstract]
Commitments and Contingencies [Text Block]	COMMITMENTS AND CONTINGENCIES Legal Proceedings The Company is party or subject to various legal proceedings and claims, either asserted or unasserted, which arise in the ordinary course of business, including proceedings and claims that relate to intellectual property matters. While the outcome of these matters cannot be predicted with certainty, the Company does not believe that the outcome of any of these matters, individually or in the aggregate, will result in losses that are materially in excess of amounts already recognized or reserved, if any. Indemnification The Company indemnifies certain customers, distributors, suppliers and subcontractors for attorney fees, damages and costs awarded against such parties in certain circumstances in which the Company's products are alleged to infringe third party intellectual property rights, including patents, registered trademarks or copyrights. The terms of the Company's indemnification obligations are generally perpetual from the effective date of the agreement. In certain cases, there are limits on and exceptions to the Company's potential liability for indemnification relating to intellectual property infringement claims. Pursuant to the Company's charter documents and separate written indemnification agreements, the Company has certain indemnification obligations to its current officers, employees and directors, as well as certain former officers and directors.

Common Stock Repurchases

Common Stock Repurchases	9 Months Ended
	Mar. 30, 2019
Common Stock Repurchases [Abstract]
Common Stock Repurchases [Text Block]	COMMON STOCK REPURCHASES On July 20, 2017, the Board of Directors of the Company authorized the repurchase of up to $1 billion of the Company's common stock. The stock repurchase authorization did not have an expiration date and the pace of repurchase activity depended on factors such as current stock price, levels of cash generation from operations, cash requirements, and other factors. All prior repurchase authorizations by the Company’s Board of Directors for the repurchase of common stock were cancelled and superseded by this repurchase authorization. On October 30, 2018, the Board of Directors of the Company authorized the repurchase of up to $ 1.5 billion of the Company’s common stock. The stock repurchase authorization does not have an expiration date and the pace of repurchase activity will depend on factors such as current stock price, levels of cash generation from operations, cash requirements, and other factors. All prior repurchase authorizations by the Company’s Board of Directors for the repurchase of common stock were cancelled and superseded by this repurchase authorization. During the nine months ended March 30, 2019 , the Company repurchased approximately 8.0 million shares of its common stock for $437.0 million . As of March 30, 2019 , the Company had remaining authorization of $1.2 billion for future share repurchases. The number of shares to be repurchased and the timing of such repurchases will be based on several factors, including the price of the Company’s common stock and general market and business conditions.

Acquisitions (Notes)

Acquisitions (Notes)	9 Months Ended
	Mar. 30, 2019
Business Combinations [Abstract]
Business Combination Disclosure [Text Block]	ACQUISITION On January 26, 2018, the Company acquired a privately-held corporation specializing in the development of high-performance USB and video extension technology. Total cash consideration paid in connection with this acquisition was $57.8 million , net of cash acquired. The Company also agreed to pay up to an additional $16.0 million if the acquired business achieves certain financial milestones for the annual period ended August 31, 2018 and annual period ending August 31, 2019. Out of the $16.0 million , $8.0 million was paid during the nine months ended March 30, 2019 . The acquired assets included $26.0 million of developed technology and $10.5 million of other intangible assets. The Company also recorded $41.9 million of goodwill in connection with this acquisition. The goodwill is not deductible for tax purposes.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	9 Months Ended
	Mar. 30, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets [Text Block]	GOODWILL AND INTANGIBLE ASSETS Goodwill The Company monitors the recoverability of goodwill recorded in connection with acquisitions, by reporting unit, annually, or more often if events or changes in circumstances indicate that the carrying amount may not be recoverable. There were no changes to goodwill for the nine months ended March 30, 2019 . No indicators or instances of impairment were identified in the nine months and fiscal year ended March 30, 2019 and June 30, 2018 , respectively. Intangible assets consisted of the following: March 30, June 30, Original Cost Accumulated Amortization Net Original Cost Accumulated Amortization Net (in thousands) Intellectual property $ 488,846 $ 443,020 $ 45,826 $ 485,465 $ 423,869 $ 61,596 Customer relationships 116,505 105,229 11,276 116,294 103,217 13,077 Trade name 9,974 8,830 1,144 9,340 8,588 752 Patents 2,500 2,500 — 2,500 2,469 31 Total amortizable purchased intangible assets 617,825 559,579 58,246 613,599 538,143 75,456 In-process research & development (IPR&D) 2,790 — 2,790 2,790 — 2,790 Total purchased intangible assets $ 620,615 $ 559,579 $ 61,036 $ 616,389 $ 538,143 $ 78,246 GOODWILL AND INTANGIBLE ASSETS Goodwill The Company monitors the recoverability of goodwill recorded in connection with acquisitions, by reporting unit, annually, or more often if events or changes in circumstances indicate that the carrying amount may not be recoverable. There were no changes to goodwill for the nine months ended March 30, 2019 . No indicators or instances of impairment were identified in the nine months and fiscal year ended March 30, 2019 and June 30, 2018 , respectively. Intangible assets consisted of the following: March 30, June 30, Original Cost Accumulated Amortization Net Original Cost Accumulated Amortization Net (in thousands) Intellectual property $ 488,846 $ 443,020 $ 45,826 $ 485,465 $ 423,869 $ 61,596 Customer relationships 116,505 105,229 11,276 116,294 103,217 13,077 Trade name 9,974 8,830 1,144 9,340 8,588 752 Patents 2,500 2,500 — 2,500 2,469 31 Total amortizable purchased intangible assets 617,825 559,579 58,246 613,599 538,143 75,456 In-process research & development (IPR&D) 2,790 — 2,790 2,790 — 2,790 Total purchased intangible assets $ 620,615 $ 559,579 $ 61,036 $ 616,389 $ 538,143 $ 78,246 The following table presents the amortization expense of intangible assets and its presentation in the Condensed Consolidated Statements of Income: Three Months Ended Nine Months Ended March 30, March 31, March 30, March 31, (in thousands) Cost of goods sold $ 5,368 $ 12,101 $ 19,151 $ 34,305 Intangible asset amortization 756 876 2,285 3,623 Total intangible asset amortization expenses $ 6,124 $ 12,977 $ 21,436 $ 37,928 The following table represents the estimated future amortization expense of intangible assets as of March 30, 2019 : Fiscal Year Amount (in thousands) Remaining three months of 2019 $ 4,793 2020 15,068 2021 13,368 2022 7,689 2023 7,205 Thereafter 10,123 Total intangible assets $ 58,246

Recently Issued Accounting Pr_2

Recently Issued Accounting Pronouncements Cumulative effect of the changes to the condensed consolidated balance sheet from the adoption of Topic 606 (Tables)	9 Months Ended
	Mar. 30, 2019
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Schedule of Prospective Adoption of New Accounting Pronouncements [Table Text Block]	The following table summarizes the impacts of adopting Topic 606 on the Company’s Condensed Consolidated Balance Sheet as of March 30, 2019 (in thousands): As Reported If Reported Under Topic 605 Effect of Adoption of Topic 606 Accounts receivable, net $ 381,152 $ 275,141 $ 106,011 Price adjustment and other revenue reserves 106,011 — 106,011
Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]	The cumulative effect of the changes to the condensed consolidated balance sheet from the adoption of Topic 606 was as follows (in thousands): As of June 30, 2018 Effect of Adoption of Topic 606 As of July 1, 2018 Accounts receivable, net $ 280,072 $ 141,652 $ 421,724 Price adjustment and other revenue reserves — 141,652 141,652

Balance Sheet Components (Table

Balance Sheet Components (Tables)	9 Months Ended
	Mar. 30, 2019
Balance Sheet Related Disclosures [Abstract]
Schedule of Inventory, Current [Table Text Block]	Inventories consist of: March 30, June 30, Inventories: (in thousands) Raw materials $ 18,799 $ 16,251 Work-in-process 172,020 173,859 Finished goods 82,013 92,280 $ 272,832 $ 282,390
Property, Plant and Equipment [Table Text Block]	Property, plant and equipment, net consists of: March 30, June 30, Property, plant and equipment, net: (in thousands) Land $ 17,731 $ 17,731 Buildings and building improvements 258,642 254,733 Machinery, equipment and software 1,358,892 1,309,487 1,635,265 1,581,951 Less: accumulated depreciation (1,063,310 ) (1,002,587 ) $ 571,955 $ 579,364
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]	Accrued salary and related expenses consist of: March 30, June 30, Accrued salary and related expenses: (in thousands) Accrued vacation $ 28,831 $ 30,695 Accrued bonus 56,187 92,288 Accrued salaries 13,711 8,210 ESPP withholding 15,634 5,158 Accrued fringe benefits 8,075 4,752 Other 5,927 10,579 $ 128,365 $ 151,682

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Mar. 30, 2019
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	Assets and liabilities measured at fair value on a recurring basis were as follows: As of March 30, 2019 As of June 30, 2018 Fair Value Measurements Using Total Fair Value Measurements Using Total Level 1 Level 2 Level 3 Level 1 Level 2 Level 3 (in thousands) Assets Cash and cash equivalents Agency securities $ — $ — $ — $ — $ — $ 13,946 $ — $ 13,946 Certificates of deposit — — — — — 6,000 — 6,000 Commercial paper — — — — — 45,063 — 45,063 Corporate debt securities — — — — — 3,819 — 3,819 Money market funds 195,805 — — 195,805 98,467 — — 98,467 U.S. Treasury securities — — — — — 30,988 — 30,988 Short term investments Certificates of deposit — 5,000 — 5,000 — 52,428 — 52,428 Commercial paper — 2,999 — 2,999 — 64,354 — 64,354 Corporate debt securities — 185,994 — 185,994 — 367,765 — 367,765 U.S. Treasury securities — 49,871 — 49,871 — 598,368 — 598,368 Other current assets Foreign currency forward contracts — 230 — 230 — 235 — 235 Total assets $ 195,805 $ 244,094 $ — $ 439,899 $ 98,467 $ 1,182,966 $ — $ 1,281,433 Liabilities Accrued expenses Foreign currency forward contracts $ — $ 496 $ — $ 496 $ — $ 1,845 $ — $ 1,845 Contingent consideration — — 9,052 9,052 — — 8,000 8,000 Other liabilities Contingent consideration — — — — — — 8,000 8,000 Total Liabilities $ — $ 496 $ 9,052 $ 9,548 $ — $ 1,845 $ 16,000 $ 17,845

Financial Instruments (Tables)

Financial Instruments (Tables)	9 Months Ended
	Mar. 30, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments, Gain (Loss) [Table Text Block]	The following tables summarize the gains (losses) from hedging activities recognized in the Company's Condensed Consolidated Statements of Income: Three Months Ended Nine Months Ended March 30, 2019 March 30, 2019 Net Revenue Cost of Goods Sold Operating Expenses Net Revenue Cost of Goods Sold Operating Expenses (in thousands) Income and expenses line items in which the effects of cash flow hedges are recorded $ 542,383 $ 201,552 $ 183,691 $ 1,757,784 $ 613,669 $ 570,588 Gain (loss) on cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from accumulated other comprehensive income into income $ 6 $ 261 $ (79 ) $ 50 $ (335 ) $ (1,906 ) Three Months Ended Nine Months Ended March 31, 2018 March 31, 2018 Net Revenue Cost of Goods Sold Operating Expenses Net Revenue Cost of Goods Sold Operating Expenses (in thousands) Income and expenses line items in which the effects of cash flow hedges are recorded $ 648,599 $ 224,653 $ 199,108 $ 1,846,913 $ 639,460 $ 596,401 Gain (loss) on cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from accumulated other comprehensive income into income $ (11 ) $ 165 $ 356 $ (64 ) $ 116 $ 1,781
Available-for-sale investments [Table Text Block]	Fair values were as follows: March 30, 2019 June 30, 2018 Amortized Cost Gross Unrealized Gain Gross Unrealized Loss Estimated Fair Value Amortized Cost Gross Unrealized Gain Gross Unrealized Loss Estimated Fair Value (in thousands) Available-for-sale investments Certificates of deposit $ 5,000 $ — $ — $ 5,000 $ 52,429 $ — $ (1 ) $ 52,428 Commercial paper 2,999 — — 2,999 64,354 — — 64,354 Corporate debt securities 186,446 21 (473 ) 185,994 369,734 39 (2,008 ) 367,765 U.S. Treasury securities 49,973 — (102 ) 49,871 600,068 10 (1,710 ) 598,368 Total available-for-sale investments $ 244,418 $ 21 $ (575 ) $ 243,864 $ 1,086,585 $ 49 $ (3,719 ) $ 1,082,915
Schedule of long-term debt [Table Text Block]	The following table summarizes the Company’s outstanding debt obligations: March 30, 2019 June 30, 2018 (in thousands) 3.45% fixed rate notes due June 2027 $ 500,000 $ 500,000 2.5% fixed rate notes due November 2018 — 500,000 3.375% fixed rate notes due March 2023 500,000 500,000 Total outstanding debt 1,000,000 1,500,000 Less: Current portion (included in "Current portion of debt") — (499,406 ) Less: Reduction for unamortized discount and debt issuance costs (7,775 ) (9,447 ) Total long-term debt $ 992,225 $ 991,147
Financial Instruments [Text Block]	FINANCIAL INSTRUMENTS Short-term investments Fair values were as follows: March 30, 2019 June 30, 2018 Amortized Cost Gross Unrealized Gain Gross Unrealized Loss Estimated Fair Value Amortized Cost Gross Unrealized Gain Gross Unrealized Loss Estimated Fair Value (in thousands) Available-for-sale investments Certificates of deposit $ 5,000 $ — $ — $ 5,000 $ 52,429 $ — $ (1 ) $ 52,428 Commercial paper 2,999 — — 2,999 64,354 — — 64,354 Corporate debt securities 186,446 21 (473 ) 185,994 369,734 39 (2,008 ) 367,765 U.S. Treasury securities 49,973 — (102 ) 49,871 600,068 10 (1,710 ) 598,368 Total available-for-sale investments $ 244,418 $ 21 $ (575 ) $ 243,864 $ 1,086,585 $ 49 $ (3,719 ) $ 1,082,915 In the three and nine months ended March 30, 2019 and June 30, 2018 , the Company did not recognize any impairment charges on short-term investments. All available-for-sale investments have maturity dates between April 1, 2019 and March 12, 2021. The Company invests in various financial instruments including U.S. Treasury securities, corporate debt securities, commercial paper, and certificates of deposit which include instruments issued or managed by industrial, financial, and utility institutions and U.S. Treasury securities which include U.S. government Treasury bills and Treasury notes. Derivative instruments and hedging activities The Company incurs expenditures denominated in non-U.S. currencies, primarily the Philippine Peso and the Thai Baht associated with the Company's manufacturing activities in the Philippines and Thailand, respectively, and the European Euro, Indian Rupee, Japanese Yen, Taiwan New Dollar, South Korean Won, Chinese Yuan and Canadian Dollar, for sales offices and research and development activities undertaken outside of the U.S. The Company has established a program that primarily utilizes foreign currency forward contracts to offset the risks associated with the effects of certain foreign currency exposures. The Company does not use these foreign currency forward contracts for trading purposes. Derivatives designated as cash flow hedging instruments The Company designates certain forward contracts as hedging instruments pursuant to Accounting Standards Codification (“ASC”) 815, Derivatives and Hedging (“ASC 815”). As of March 30, 2019 and June 30, 2018 , the notional amounts of the forward contracts the Company held to purchase international currencies were $44.4 million and $49.7 million , respectively, and the notional amounts of forward contracts the Company held to sell international currencies were $0 and $1.2 million , respectively. Derivatives not designated as hedging instruments As of March 30, 2019 and June 30, 2018 , the notional amounts of the forward contracts the Company held to purchase international currencies were $19.9 million and $21.1 million , respectively, and the notional amounts of forward contracts the Company held to sell international currencies were $21.9 million and $21.3 million , respectively. The Company's foreign currency forward contract gains or losses included in the Condensed Consolidated Statements of Income were not material for the three and nine months ended March 30, 2019 and March 31, 2018 . Effect of hedge accounting on the Condensed Consolidated Statements of Income The following tables summarize the gains (losses) from hedging activities recognized in the Company's Condensed Consolidated Statements of Income: Three Months Ended Nine Months Ended March 30, 2019 March 30, 2019 Net Revenue Cost of Goods Sold Operating Expenses Net Revenue Cost of Goods Sold Operating Expenses (in thousands) Income and expenses line items in which the effects of cash flow hedges are recorded $ 542,383 $ 201,552 $ 183,691 $ 1,757,784 $ 613,669 $ 570,588 Gain (loss) on cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from accumulated other comprehensive income into income $ 6 $ 261 $ (79 ) $ 50 $ (335 ) $ (1,906 ) Three Months Ended Nine Months Ended March 31, 2018 March 31, 2018 Net Revenue Cost of Goods Sold Operating Expenses Net Revenue Cost of Goods Sold Operating Expenses (in thousands) Income and expenses line items in which the effects of cash flow hedges are recorded $ 648,599 $ 224,653 $ 199,108 $ 1,846,913 $ 639,460 $ 596,401 Gain (loss) on cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from accumulated other comprehensive income into income $ (11 ) $ 165 $ 356 $ (64 ) $ 116 $ 1,781 Outstanding debt obligations The following table summarizes the Company’s outstanding debt obligations: March 30, 2019 June 30, 2018 (in thousands) 3.45% fixed rate notes due June 2027 $ 500,000 $ 500,000 2.5% fixed rate notes due November 2018 — 500,000 3.375% fixed rate notes due March 2023 500,000 500,000 Total outstanding debt 1,000,000 1,500,000 Less: Current portion (included in "Current portion of debt") — (499,406 ) Less: Reduction for unamortized discount and debt issuance costs (7,775 ) (9,447 ) Total long-term debt $ 992,225 $ 991,147 On June 15, 2017, the Company completed a public offering of $500 million aggregate principal amount of the Company's 3.45% senior unsecured and unsubordinated notes due in June 2027 (“2027 Notes”), with an effective interest rate of 3.5% . Interest on the 2027 Notes is payable semi-annually in arrears on June 15 and December 15 of each year, commencing on December 15, 2017. The net proceeds of this offering were approximately $495.2 million , after issuing at a discount and deducting paid expenses. On November 21, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 2.5% coupon senior unsecured and unsubordinated notes due in November 2018 (“2018 Notes”), with an effective interest rate of 2.6%. Interest on the 2018 Notes is payable semi-annually in arrears on May 15 and November 15 of each year, commencing on May 15, 2014. The net proceeds of this offering were approximately $494.5 million , after issuing at a discount and deducting paid expenses. In November of 2018, the Company repaid the entire $500 million in principal and any outstanding interest, related to these outstanding notes. On March 18, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 3.375% senior unsecured and unsubordinated notes due in March 2023 (“2023 Notes”), with an effective interest rate of 3.5% . Interest on the 2023 Notes is payable semi-annually in arrears on March 15 and September 15 of each year. The net proceeds of this offering were approximately $490.0 million , after issuing at a discount and deducting paid expenses. The debt indentures that govern the 2027 Notes and the 2023 Notes include covenants that limit the Company's ability to grant liens on its facilities and to enter into sale and leaseback transactions, which could limit the Company's ability to secure additional debt funding in the future. In circumstances involving a change of control of the Company followed by a downgrade of the rating of the 2027 Notes or the 2023 Notes, the Company would be required to make an offer to repurchase the affected notes at a purchase price equal to 101% of the aggregate principal amount of such notes, plus accrued and unpaid interest. The Company accounts for all the notes above based on their amortized cost. The discount and expenses are being amortized to Interest and other income (expense), net in the Condensed Consolidated Statements of Income over the life of the notes. The interest expense is recorded in Interest and other income (expense), net in the Condensed Consolidated Statements of Income. Amortized discount and expenses, as well as interest expense associated with the notes, were $8.9 million and $12.4 million during the three months ended March 30, 2019 and March 31, 2018 , respectively. Amortized discount and expenses, as well as interest expense associated with the notes, were $32.5 million and $37.1 million during the nine months ended March 30, 2019 and March 31, 2018 , respectively. The estimated fair value of the Company’s outstanding debt obligations was approximately $985 million as of March 30, 2019 . The estimated fair value of the debt is based primarily on observable market inputs and is a Level 2 measurement. The Company recorded interest expense of $9.3 million and $12.4 million during the three months ended March 30, 2019 , and March 31, 2018 , respectively. The Company recorded interest expense of $33.9 million and $37.6 million during the nine months ended March 30, 2019 and March 31, 2018 , respectively. Other Financial Instruments For the balance of the Company’s financial instruments, cash equivalents, accounts receivable, accounts payable and other accrued liabilities, the carrying amounts approximate fair value due to their short maturities.

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	9 Months Ended
	Mar. 30, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]	The following tables show total stock-based compensation expense by type of award, and the resulting tax effect, included in the Condensed Consolidated Statements of Income for the three and nine months ended March 30, 2019 and March 31, 2018 , respectively: Three Months Ended March 30, 2019 March 31, 2018 Stock Options Restricted Stock Units Employee Stock Purchase Plan Total Stock Options Restricted Stock Units Employee Stock Purchase Plan Total (in thousands) Cost of goods sold $ 8 $ 1,951 $ 654 $ 2,613 $ 35 $ 2,003 $ 537 $ 2,575 Research and development 5 9,399 1,658 11,062 13 8,725 1,339 10,077 Selling, general and administrative 64 8,184 897 9,145 51 7,218 684 7,953 Pre-tax stock-based compensation expense $ 77 $ 19,534 $ 3,209 $ 22,820 $ 99 $ 17,946 $ 2,560 $ 20,605 Less: income tax effect 1,946 2,053 Net stock-based compensation expense $ 20,874 $ 18,552 Nine Months Ended March 30, 2019 March 31, 2018 Stock Options Restricted Stock Units Employee Stock Purchase Plan Total Stock Options Restricted Stock Units Employee Stock Purchase Plan Total (in thousands) Cost of goods sold $ 28 $ 5,597 $ 1,656 $ 7,281 $ 196 $ 5,783 $ 1,482 $ 7,461 Research and development 27 26,783 3,948 30,758 507 24,212 3,342 28,061 Selling, general and administrative 178 24,600 2,156 26,934 636 21,004 1,770 23,410 Pre-tax stock-based compensation expense $ 233 $ 56,980 $ 7,760 $ 64,973 $ 1,339 $ 50,999 $ 6,594 $ 58,932 Less: income tax effect 6,214 6,830 Net stock-based compensation expense $ 58,759 $ 52,102
Share-based Compensation Arrangements by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding [Table Text Block]	The following table summarizes outstanding, exercisable and vested and expected to vest stock options as of March 30, 2019 and related activity for the nine months ended March 30, 2019 : Number of Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (in Years) Aggregate Intrinsic Value (1) Balance at June 30, 2018 1,688,253 $ 27.72 Options Granted — — Options Exercised (699,416 ) 27.13 Options Cancelled (3,439 ) 28.08 Balance at March 30, 2019 985,398 $ 28.14 1.3 $ 25,692,173 Exercisable, March 30, 2019 985,398 $ 28.14 1.3 $ 25,692,173 Vested and expected to vest, March 30, 2019 985,398 $ 28.14 1.3 $ 25,692,173 (1) Aggregate intrinsic value represents the difference between the exercise price and the closing price per share of the Company’s common stock on March 29, 2019, the last business day preceding the fiscal quarter-end, multiplied by the number of options outstanding, exercisable or vested and expected to vest as of March 30, 2019.
Share-based Compensation Arrangements by Share-based Payment Award, Restricted Stock Units, Vested and Expected to Vest [Table Text Block]	The following table summarizes the outstanding and expected to vest RSUs and other awards as of March 30, 2019 and related activity during the nine months ended March 30, 2019 : Number of Shares Weighted Average Aggregate Intrinsic Value (1) Balance at June 30, 2018 5,524,432 Restricted stock units and other awards granted 1,614,379 Restricted stock units and other awards released (1,377,399 ) Restricted stock units and other awards cancelled (458,762 ) Balance at March 30, 2019 5,302,650 2.7 $ 287,456,657 Outstanding and expected to vest, March 30, 2019 4,439,502 2.7 $ 240,665,404 (1) Aggregate intrinsic value for RSUs and other awards represents the closing price per share of the Company’s common stock on March 29, 2019, the last business day preceding the fiscal quarter-end, multiplied by the number of RSUs outstanding or expected to vest as of March 30, 2019.
Share-based Compensation Arrangements by Share-based Payment Award, Performance-Based Units, Vested and Expected to Vest [Table Text Block]	The following table summarizes the number of MSUs outstanding and expected to vest as of March 30, 2019 and their activity during the nine months ended March 30, 2019 : Number of Shares Weighted Average Aggregate Intrinsic (1) Balance at June 30, 2018 1,079,064 Market stock units granted 247,804 Market stock units released (13,594 ) Market stock units cancelled (264,742 ) Balance at March 30, 2019 1,048,532 2.7 $ 56,840,920 Outstanding and expected to vest, March 30, 2019 976,524 2.7 $ 52,937,345 (1) Aggregate intrinsic value for MSUs represents the closing price per share of the Company’s common stock on March 29, 2019, the last business day preceding the fiscal quarter-end, multiplied by the number of MSUs outstanding or expected to vest as of March 30, 2019.
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]	The fair value of 2008 ESPP rights granted to employees has been estimated at the date of grant using the Black-Scholes option valuation model using the following assumptions for the offering periods outstanding: Three Months Ended Nine Months Ended March 30, 2019 March 31, 2018 March 30, 2019 March 31, 2018 Expected holding period (in years) 0.5 years 0.5 years 0.5 years 0.5 years Risk-free interest rate 2.4% - 2.6% 1.1% - 1.5% 1.6% - 2.6% 0.8% - 1.5% Expected stock price volatility 27.5 % - 28.9% 20.5% - 20.7% 19.6% - 32.7 % 19.1% - 24.7% Dividend yield 2.8% - 3.1% 3.0% - 3.1% 2.8% - 3.1% 3.0% - 3.4%

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Mar. 30, 2019
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	The following table sets forth the computation of basic and diluted earnings per share: Three Months Ended Nine Months Ended March 30, March 31, March 30, March 31, (in thousands, except per share data) Numerator for basic earnings per share and diluted earnings per share Net income $ 130,613 $ 193,627 $ 459,928 $ 273,146 Denominator for basic earnings per share 273,221 280,850 275,831 281,525 Effect of dilutive securities: Stock options, ESPP, RSUs, and MSUs 3,389 5,031 3,849 4,696 Denominator for diluted earnings per share 276,610 285,881 279,680 286,221 Earnings per share Basic $ 0.48 $ 0.69 $ 1.67 $ 0.97 Diluted $ 0.47 $ 0.68 $ 1.64 $ 0.95

Segment Information (Tables)

Segment Information (Tables)	9 Months Ended
	Mar. 30, 2019
Segment Reporting [Abstract]
Schedule of Revenue from External Customers by Geographical Areas [Table Text Block]	Net revenues from unaffiliated customers by geographic region were as follows: Three Months Ended Nine Months Ended March 30, 2019 March 31, 2018 March 30, 2019 March 31, 2018 (in thousands) United States $ 63,970 $ 75,760 $ 200,944 $ 223,021 China 183,753 219,160 611,768 662,114 Rest of Asia 176,396 222,207 583,616 586,109 Europe 104,124 114,254 316,155 329,939 Rest of World 14,140 17,218 45,301 45,730 $ 542,383 $ 648,599 $ 1,757,784 $ 1,846,913
Schedule of Long Lived Assets by Geographical Areas [Table Text Block]	Net long-lived assets by geographic region were as follows: March 30, June 30, (in thousands) United States $ 359,743 $ 361,432 Philippines 110,214 120,657 Rest of World 101,998 97,275 $ 571,955 $ 579,364

Comprehensive Income Loss (Tabl

Comprehensive Income Loss (Tables)	9 Months Ended
	Mar. 30, 2019
Statement of Comprehensive Income [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	The changes in accumulated other comprehensive income (loss) by component and related tax effects in the nine months ended March 30, 2019 and March 31, 2018 were as follows: (in thousands) Unrealized Gains and (Losses) on Intercompany Receivables Unrealized Gains and (Losses) on Post-Retirement Benefits Cumulative Translation Adjustment Unrealized Gains and (Losses) on Cash Flow Hedges Unrealized Gains and (Losses) on Available-For-Sale Securities Total June 30, 2018 $ (6,280 ) $ (2,516 ) $ (1,136 ) $ (1,383 ) $ (3,670 ) $ (14,985 ) Other comprehensive income (loss) before reclassifications — — — (783 ) 3,247 2,464 Amounts reclassified out of accumulated other comprehensive loss (income) — 292 — 2,191 — 2,483 Tax effects — (60 ) (241 ) (131 ) (432 ) Other comprehensive income, net — 232 — 1,167 3,116 4,515 March 30, 2019 $ (6,280 ) $ (2,284 ) $ (1,136 ) $ (216 ) $ (554 ) $ (10,470 ) (in thousands) Unrealized Gains and (Losses) on Intercompany Receivables Unrealized Gains and (Losses) on Post-Retirement Benefits Cumulative Translation Adjustment Unrealized Gains and (Losses) on Cash Flow Hedges Unrealized Gains and (Losses) on Available-For-Sale Securities Total June 24, 2017 $ (6,280 ) $ (1,258 ) $ (1,136 ) $ 18 $ (1,234 ) $ (9,890 ) Other comprehensive income (loss) before reclassifications — — — 2,012 (3,707 ) (1,695 ) Amounts reclassified out of accumulated other comprehensive loss (income) — 154 — (1,834 ) — (1,680 ) Tax effects — (168 ) — (45 ) 274 61 Other comprehensive income (loss), net — (14 ) — 133 (3,433 ) (3,314 ) March 31, 2018 $ (6,280 ) $ (1,272 ) $ (1,136 ) $ 151 $ (4,667 ) $ (13,204 )

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	9 Months Ended
	Mar. 30, 2019	Mar. 31, 2018
Goodwill [Line Items]
Goodwill and Intangible Assets Disclosure [Text Block]	GOODWILL AND INTANGIBLE ASSETS Goodwill The Company monitors the recoverability of goodwill recorded in connection with acquisitions, by reporting unit, annually, or more often if events or changes in circumstances indicate that the carrying amount may not be recoverable. There were no changes to goodwill for the nine months ended March 30, 2019 . No indicators or instances of impairment were identified in the nine months and fiscal year ended March 30, 2019 and June 30, 2018 , respectively. Intangible assets consisted of the following: March 30, June 30, Original Cost Accumulated Amortization Net Original Cost Accumulated Amortization Net (in thousands) Intellectual property $ 488,846 $ 443,020 $ 45,826 $ 485,465 $ 423,869 $ 61,596 Customer relationships 116,505 105,229 11,276 116,294 103,217 13,077 Trade name 9,974 8,830 1,144 9,340 8,588 752 Patents 2,500 2,500 — 2,500 2,469 31 Total amortizable purchased intangible assets 617,825 559,579 58,246 613,599 538,143 75,456 In-process research & development (IPR&D) 2,790 — 2,790 2,790 — 2,790 Total purchased intangible assets $ 620,615 $ 559,579 $ 61,036 $ 616,389 $ 538,143 $ 78,246 GOODWILL AND INTANGIBLE ASSETS Goodwill The Company monitors the recoverability of goodwill recorded in connection with acquisitions, by reporting unit, annually, or more often if events or changes in circumstances indicate that the carrying amount may not be recoverable. There were no changes to goodwill for the nine months ended March 30, 2019 . No indicators or instances of impairment were identified in the nine months and fiscal year ended March 30, 2019 and June 30, 2018 , respectively. Intangible assets consisted of the following: March 30, June 30, Original Cost Accumulated Amortization Net Original Cost Accumulated Amortization Net (in thousands) Intellectual property $ 488,846 $ 443,020 $ 45,826 $ 485,465 $ 423,869 $ 61,596 Customer relationships 116,505 105,229 11,276 116,294 103,217 13,077 Trade name 9,974 8,830 1,144 9,340 8,588 752 Patents 2,500 2,500 — 2,500 2,469 31 Total amortizable purchased intangible assets 617,825 559,579 58,246 613,599 538,143 75,456 In-process research & development (IPR&D) 2,790 — 2,790 2,790 — 2,790 Total purchased intangible assets $ 620,615 $ 559,579 $ 61,036 $ 616,389 $ 538,143 $ 78,246 The following table presents the amortization expense of intangible assets and its presentation in the Condensed Consolidated Statements of Income: Three Months Ended Nine Months Ended March 30, March 31, March 30, March 31, (in thousands) Cost of goods sold $ 5,368 $ 12,101 $ 19,151 $ 34,305 Intangible asset amortization 756 876 2,285 3,623 Total intangible asset amortization expenses $ 6,124 $ 12,977 $ 21,436 $ 37,928 The following table represents the estimated future amortization expense of intangible assets as of March 30, 2019 : Fiscal Year Amount (in thousands) Remaining three months of 2019 $ 4,793 2020 15,068 2021 13,368 2022 7,689 2023 7,205 Thereafter 10,123 Total intangible assets $ 58,246
Schedule of intangible assets [Table Text Block]	Intangible assets consisted of the following: March 30, June 30, Original Cost Accumulated Amortization Net Original Cost Accumulated Amortization Net (in thousands) Intellectual property $ 488,846 $ 443,020 $ 45,826 $ 485,465 $ 423,869 $ 61,596 Customer relationships 116,505 105,229 11,276 116,294 103,217 13,077 Trade name 9,974 8,830 1,144 9,340 8,588 752 Patents 2,500 2,500 — 2,500 2,469 31 Total amortizable purchased intangible assets 617,825 559,579 58,246 613,599 538,143 75,456 In-process research & development (IPR&D) 2,790 — 2,790 2,790 — 2,790 Total purchased intangible assets $ 620,615 $ 559,579 $ 61,036 $ 616,389 $ 538,143 $ 78,246
Schedule of amortization expense allocation of intangible assets [Table Text Block]		The following table presents the amortization expense of intangible assets and its presentation in the Condensed Consolidated Statements of Income: Three Months Ended Nine Months Ended March 30, March 31, March 30, March 31, (in thousands) Cost of goods sold $ 5,368 $ 12,101 $ 19,151 $ 34,305 Intangible asset amortization 756 876 2,285 3,623 Total intangible asset amortization expenses $ 6,124 $ 12,977 $ 21,436 $ 37,928
Estimated future amortization expense of intangible assets [Table Text Block]	The following table represents the estimated future amortization expense of intangible assets as of March 30, 2019 : Fiscal Year Amount (in thousands) Remaining three months of 2019 $ 4,793 2020 15,068 2021 13,368 2022 7,689 2023 7,205 Thereafter 10,123 Total intangible assets $ 58,246

Recently Issued Accounting Pr_3

Recently Issued Accounting Pronouncements (Details) - USD ($)	3 Months Ended	9 Months Ended
	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018	Jul. 01, 2018	Jun. 30, 2018
New Accounting Pronouncement, Early Adoption [Line Items]
Accounts Receivable, Net, Current		$ 381,152,000			$ 280,072,000
Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]		The cumulative effect of the changes to the condensed consolidated balance sheet from the adoption of Topic 606 was as follows (in thousands): As of June 30, 2018 Effect of Adoption of Topic 606 As of July 1, 2018 Accounts receivable, net $ 280,072 $ 141,652 $ 421,724 Price adjustment and other revenue reserves — 141,652 141,652
Discrete income tax benefit generated by the settlement of share-based awards	$ 8,300,000
Cash flow from operating activities operating activities		$ 638,373,000	$ 672,805,000
Accounts Receivable, Net				$ 421,724,000	280,072,000
Price adjustment and other revenue reserves		106,011,000			$ 0
Adjustments for New Accounting Pronouncement [Member]
New Accounting Pronouncement, Early Adoption [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets				$ 141,652,000
Accounting Standards Update 2014-09 [Member]
New Accounting Pronouncement, Early Adoption [Line Items]
Accounts Receivable, Net, Current		$ 275,141,000

Recently Issued Accounting Pr_4

Recently Issued Accounting Pronouncements Schedule of prospective adoption of new accounting pronouncements (Details) - USD ($)	3 Months Ended
	Mar. 30, 2019	Jul. 01, 2018
Item Effected [Line Items]
Income Tax Effects Allocated Directly to Equity, Prior Period Adjustment	$ 2,500,000
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	$ 106,011,000
Adjustments for New Accounting Pronouncement [Member]
Item Effected [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets		$ 141,652,000

Balance Sheet Components (Detai

Balance Sheet Components (Details) - USD ($) $ in Thousands	Mar. 30, 2019	Jun. 30, 2018
Inventories:
Raw materials	$ 18,799	$ 16,251
Work-in-process	172,020	173,859
Finished goods	82,013	92,280
Inventory, net	272,832	282,390
Property, plant and equipment:
Land	17,731	17,731
Buildings and building improvements	258,642	254,733
Machinery and equipment	1,358,892	1,309,487
Property, plant and equipment, gross	1,635,265	1,581,951
Less: accumulated depreciation and amortization	(1,063,310)	(1,002,587)
Property, plant and equipment, net	571,955	579,364
Employee-related Liabilities, Current [Abstract]
Accrued Vacation	28,831	30,695
Accrued Bonuses	56,187	92,288
Accrued Salaries	13,711	8,210
Accrued Employee Stock Purchase Program Withholding	15,634	5,158
Accrued Employee Benefits	8,075	4,752
Other	5,927	10,579
Accrued salary and related expenses	$ 128,365	$ 151,682

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018	Jun. 30, 2018	Jun. 24, 2017
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impairment of long-lived assets	$ 0	$ 0	$ 753	$ 892
Interest Expense, Debt	8,900	12,400	32,500	37,100
Cash and cash equivalents	1,654,563	1,629,593	1,654,563	1,629,593	$ 1,543,484	$ 2,246,121
Available-for-sale Securities					1,082,915
Business Combination, Contingent Consideration, Liability		$ 16,000		$ 16,000	8,000
Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Assets	439,899		439,899		1,281,433
Total Liabilities	9,548		9,548		17,845
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Assets	195,805		195,805		98,467
Total Liabilities	0		0		0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Assets	244,094		244,094		1,182,966
Total Liabilities	496		496		1,845
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Assets	0		0		0
Total Liabilities	9,052		9,052		16,000
Money Market Funds [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	195,805		195,805		98,467
Money Market Funds [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	195,805		195,805		98,467
Money Market Funds [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents					0
Money Market Funds [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents					0
Commercial paper | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0		0		45,063
Available-for-sale Securities	2,999		2,999		64,354
Commercial paper | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0		0		45,063
Available-for-sale Securities	2,999		2,999		64,354
Corporate debt securities | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0		0		3,819
Available-for-sale Securities	185,994		185,994		367,765
Corporate debt securities | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0		0		3,819
Available-for-sale Securities	185,994		185,994		367,765
US Treasury Securities [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	0		0		30,988
Available-for-sale Securities	49,871		49,871		598,368
US Treasury Securities [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities					0
US Treasury Securities [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0		0		30,988
Available-for-sale Securities	49,871		49,871		598,368
US Treasury Securities [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities					0
Foreign Exchange Forward [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency forward contracts	230		230		235
Foreign currency forward contracts	496		496		1,845
Foreign Exchange Forward [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency forward contracts					0
Foreign currency forward contracts	0		0		0
Foreign Exchange Forward [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency forward contracts	230		230		235
Foreign currency forward contracts	496		496		1,845
Foreign Exchange Forward [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency forward contracts					0
Foreign currency forward contracts	0		0		0
Accrued Liabilities [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Business Combination, Contingent Consideration, Liability	9,052		9,052		8,000
Accrued Liabilities [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Business Combination, Contingent Consideration, Liability	9,052		9,052
Certificates of deposit | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0		0		6,000
Available-for-sale Securities	5,000		5,000		52,428
Certificates of deposit | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0		0		6,000
Available-for-sale Securities	5,000		5,000		52,428
Agency Securities | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0		0		13,946
Agency Securities | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0		0		0
Agency Securities | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0		0		13,946
Agency Securities | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0		0		0
Other Liabilities [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Business Combination, Contingent Consideration, Liability	$ 0		$ 0		8,000
Other Liabilities [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Business Combination, Contingent Consideration, Liability					$ 8,000

Financial Instruments, Short-te

Financial Instruments, Short-term Investments (Details) - USD ($) $ in Thousands	Mar. 30, 2019	Jun. 30, 2018
Debt Securities, Available-for-sale [Abstract]
Estimated Fair Value		$ 1,082,915
Debt Securities, Available-for-sale, Amortized Cost	$ 244,418	1,086,585
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	21	49
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	575	3,719
Debt Securities, Available-for-sale	243,864
Certificates of deposit
Debt Securities, Available-for-sale [Abstract]
Debt Securities, Available-for-sale, Amortized Cost	5,000	52,429
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	0	0
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	0	1
Debt Securities, Available-for-sale	5,000	52,428
Commercial paper
Debt Securities, Available-for-sale [Abstract]
Debt Securities, Available-for-sale, Amortized Cost	2,999	64,354
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax		0
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax		0
Debt Securities, Available-for-sale	2,999	64,354
Corporate debt securities
Debt Securities, Available-for-sale [Abstract]
Debt Securities, Available-for-sale, Amortized Cost	186,446	369,734
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	21	39
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	473	2,008
Debt Securities, Available-for-sale	185,994	367,765
U.S. Treasury securities
Debt Securities, Available-for-sale [Abstract]
Debt Securities, Available-for-sale, Amortized Cost	49,973	600,068
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	0	10
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	102	1,710
Debt Securities, Available-for-sale	$ 49,871	$ 598,368

Financial Instruments Financial

Financial Instruments Financial Instruments, Securities Received as Consideration (Details) - USD ($) $ in Thousands	9 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Jun. 30, 2018
Investment [Line Items]
Proceeds from sale of shares	$ 30,192	$ 100,004
Estimated Fair Value			$ 1,082,915
Not Designated as Hedging Instrument [Member] | Forward contracts held to purchase U.S. dollars [Member]
Investment [Line Items]
Derivative, Notional Amount	19,900		21,100
Not Designated as Hedging Instrument [Member] | Forward contracts held to sell U.S. dollars [Member]
Investment [Line Items]
Derivative, Notional Amount	21,900		21,300
Designated as Hedging Instrument [Member] | Forward contracts held to purchase U.S. dollars [Member] | Cash Flow Hedging [Member]
Investment [Line Items]
Derivative, Notional Amount	44,400		49,700
Designated as Hedging Instrument [Member] | Forward contracts held to sell U.S. dollars [Member] | Cash Flow Hedging [Member]
Investment [Line Items]
Derivative, Notional Amount	$ 0		$ 1,200

Financial Instruments, Balance

Financial Instruments, Balance Sheet Location (Details) - USD ($) $ in Millions	Mar. 30, 2019	Jun. 30, 2018
Derivatives designated as hedging instruments [Member] | Cash Flow Hedging [Member] | Forward contracts held to purchase U.S. dollars [Member]
Derivatives, Fair Value [Line Items]
Notional amount of derivatives	$ 44.4	$ 49.7
Derivatives designated as hedging instruments [Member] | Cash Flow Hedging [Member] | Forward contracts held to sell U.S. dollars [Member]
Derivatives, Fair Value [Line Items]
Notional amount of derivatives	0	1.2
Derivatives not designated as hedging instruments [Member] | Forward contracts held to purchase U.S. dollars [Member]
Derivatives, Fair Value [Line Items]
Notional amount of derivatives	19.9	21.1
Derivatives not designated as hedging instruments [Member] | Forward contracts held to sell U.S. dollars [Member]
Derivatives, Fair Value [Line Items]
Notional amount of derivatives	$ 21.9	$ 21.3

Financial Instruments, Long-ter

Financial Instruments, Long-term Debt (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018	Jun. 30, 2018	Jun. 24, 2017	Mar. 30, 2013
Debt Instrument [Line Items]
Debt, Long-term and Short-term, Combined Amount	$ 1,000,000		$ 1,000,000		$ 1,500,000
Short-term Debt	0		0		(499,406)
Less: Reduction for unamortized discount and debt issuance costs	(7,775)				(9,447)
Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed						101.00%
Interest expense relating to the Notes	8,900	$ 12,400	32,500	$ 37,100
Estimated fair value of long-term debt	985,000		985,000
Interest Expense	9,300	12,400	33,900	37,600
Secured Long-term Debt, Noncurrent	992,225		992,225		991,147
Fixed Rate Note Due June 2027 at 3 Point 45 Percent [Member]
Debt Instrument [Line Items]
Long-term debt	500,000		500,000		500,000	$ 500,000
Fixed Rate Note Due November 2018 at 2 Point 50 Percent [Member]
Debt Instrument [Line Items]
Long-term debt	$ 0	$ 500,000	$ 0	$ 500,000	$ 500,000
Stated interest rate of the notes	2.50%		2.50%		2.50%
Fxed Rate Note Due March 2023 at 3 Point 375 Percent [Member]
Debt Instrument [Line Items]
Long-term debt	$ 500,000		$ 500,000		$ 500,000		$ 500,000
Effective interest rate of the Notes							3.50%
proceeds from issuance of long term debt 3							$ 490,000
FixedRateNoteDueJune2027at3Point450Percent[Member] [Member]
Debt Instrument [Line Items]
Stated interest rate of the notes	3.45%		3.45%		3.45%	3.45%
Fixed Rate Note Due June 2027 at 3 Point 50 Percent [Member] [Domain]
Debt Instrument [Line Items]
Effective interest rate of the Notes						3.50%
Fixed Rate Note Due June 2027 at 3 Point 50 Percent [Member] [Member]
Debt Instrument [Line Items]
Net Proceeds From Issuance of Long Term Debt 5						$ 495,200
Fixed Rate Note Due March 2023 at 3 Point 375 Percent [Member]
Debt Instrument [Line Items]
Stated interest rate of the notes	3.375%		3.375%		3.375%		3.375%

Financial Instruments Gain (Los

Financial Instruments Gain (Loss) from Hedging Activities (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018
Derivative [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	$ 542,383	$ 648,599	$ 1,757,784	$ 1,846,913
Cost of goods sold	201,552	224,653	613,669	639,460
Revenues	542,383	648,599	1,757,784	1,846,913
Operating Expenses	183,691	199,108	570,588	596,401
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax			(2,483)	1,680
Accumulated Net Gain (Loss) from Cost of Good Solds Attributable to Parent [Member] [Member]
Derivative [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	261	165	(335)	116
Accumulated Net Gain (Loss) from Operating Expense Attributable to Parent [Member] [Member] [Member]
Derivative [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	(79)	356	(1,906)	1,781
Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]
Derivative [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	$ 6	$ (11)	$ 50	$ (64)

Stock-Based Compensation (Detai

Stock-Based Compensation (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	$ 22,820	$ 20,605	$ 64,973	$ 58,932
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense	1,946	2,053	6,214	6,830
Net stock-based compensation expense	20,874	18,552	58,759	52,102
Cost of Sales [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	2,613	2,575	7,281	7,461
Research and Development Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	11,062	10,077	30,758	28,061
General and Administrative Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	9,145	7,953
Stock options [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	77	99	233	1,339
Stock options [Member] | Cost of Sales [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	8	35	28	196
Stock options [Member] | Research and Development Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	5	13	27	507
Stock options [Member] | General and Administrative Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	64	51
Restricted Stock Units (RSUs) [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	19,534	17,946
Restricted Stock Units (RSUs) [Member] | Cost of Sales [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	1,951	2,003	5,597	5,783
Restricted Stock Units (RSUs) [Member] | Research and Development Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	9,399	8,725	26,783	24,212
Restricted Stock Units (RSUs) [Member] | General and Administrative Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	8,184	7,218
ESP Plan [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	3,209	2,560	7,760	6,594
ESP Plan [Member] | Cost of Sales [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	654	537	1,656	1,482
ESP Plan [Member] | Research and Development Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	1,658	1,339	3,948	3,342
ESP Plan [Member] | General and Administrative Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	897	684
Market stock units [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	$ 3,000	$ 2,200	$ 8,300	$ 5,800

Stock-Based Compensation, Stock

Stock-Based Compensation, Stock Option Plans (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	9 Months Ended
	Mar. 30, 2019	Mar. 30, 2019	Mar. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Unrecognized compensation costs related to unvested units	$ 162,600	$ 162,600
Weighted average period of recognition for unrecognized compensation costs (in years)		2 years 8 months	2 years 8 months
Stock options [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Options outstanding, beginning		1,688,253,000
Options Granted	0	0
Options Exercised		(699,416,000)
Options Cancelled		(3,439,000)
Options outstanding, ending	985,398,000	985,398,000
Options exercisable, number of shares	985,398,000	985,398,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Options outstanding, weighted average exercise price, beginning (per share)		$ 27.72
Options granted, weighted average exercise price (per share)		0
Options exercised, weighted average exercise price (per share)		27,130
Options cancelled, weighted average exercise price (per share)		28,080
Options outstanding, weighted average exercise price, ending (per share)	$ 28,140	28,140
Options exercisable, weighted average exercise price (per share)	28,140	28,140
Options vested and expected to vest, weighted average exercise price (per share)	$ 28,140	$ 28,140
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Options outstanding, weighted average remaining contractual term (in years)		1 year 4 months
Options exercisable, weighted average remaining contractual term (in years)		1 year 4 months
Options vested and expected to vest, weighted average remaining contractual term (in years)		1 year 4 months
Options outstanding, aggregate intrinsic value	$ 25,692,173	$ 25,692,173
Options exercisable, aggregate intrinsic value	25,692,173	25,692,173
Options vested and expected to vest, aggregate intrinsic value	25,692,173	25,692,173
Unrecognized compensation costs related to unvested units	$ 0	$ 0

Stock-Based Compensation, Restr

Stock-Based Compensation, Restricted Stock Units (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018
Outstanding and expected to vest RSUs [Roll Forward]
Outstanding, beginning		5,300,000
Outstanding, ending	1,000,000		1,000,000
Unrecognized compensation costs related to unvested units	$ 162,600		$ 162,600
Weighted average period of recognition for unrecognized compensation costs (in years)			2 years 8 months	2 years 8 months
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average grant date fair value (per share)	$ 51.01	$ 54.81	$ 54.04	$ 44.49
Outstanding and expected to vest RSUs [Roll Forward]
Outstanding, beginning			5,524,432,000
Granted			1,614,379,000
Released			(1,377,399,000)
Cancelled			(458,762,000)
Outstanding, ending	5,302,650,000		5,302,650,000
Expected to vest, number of shares	4,439,502,000		4,439,502,000
Outstanding, weighted average remaining contractual term (in years)			2 years 8 months
Restricted stock units vested and expected to vest, weighted average remaining contractual term 1			2 years 8 months
Outstanding, aggregate intrinsic value	$ 287,456,657		$ 287,456,657
Restricted stock units expected to vest, aggregate intrinsic value	$ 240,665,404		240,665,404
Value of restricted stock unit shares withheld for withholding tax			$ 23,000

Stock-Based Compensation Stock

Stock-Based Compensation Stock Based Compensation, Market Stock Units (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangements by Share-based Payment Award, Performance-Based Units, Vested and Expected to Vest [Table Text Block]			The following table summarizes the number of MSUs outstanding and expected to vest as of March 30, 2019 and their activity during the nine months ended March 30, 2019 : Number of Shares Weighted Average Aggregate Intrinsic (1) Balance at June 30, 2018 1,079,064 Market stock units granted 247,804 Market stock units released (13,594 ) Market stock units cancelled (264,742 ) Balance at March 30, 2019 1,048,532 2.7 $ 56,840,920 Outstanding and expected to vest, March 30, 2019 976,524 2.7 $ 52,937,345 (1) Aggregate intrinsic value for MSUs represents the closing price per share of the Company’s common stock on March 29, 2019, the last business day preceding the fiscal quarter-end, multiplied by the number of MSUs outstanding or expected to vest as of March 30, 2019.
Allocated Share-based Compensation Expense	$ 22,820	$ 20,605	$ 64,973	$ 58,932
Outstanding and expected to vest MSUs [Roll Forward]
Outstanding, beginning		5,300,000
Outstanding, ending	1,000,000		1,000,000
Unrecognized compensation costs related to unvested units	$ 162,600		$ 162,600
Weighted average period of recognition for unrecognized compensation costs (in years)			2 years 8 months	2 years 8 months
Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	$ 3,000	$ 2,200	$ 8,300	$ 5,800
Market Stock Units [Member]
Outstanding and expected to vest MSUs [Roll Forward]
Weighted average grant date fair value (per share)			$ 75.48	$ 51.03
Outstanding, beginning			1,079,064,000
Granted			247,804,000
Released			(13,594,000)
Cancelled			(264,742,000)
Outstanding, ending	1,048,532,000		1,048,532,000
Expected to vest, number of shares	976,524,000		976,524,000
Outstanding, weighted average remaining contractual term (in years)			2 years 8 months
Outstanding and expected to Vest, weighted average remaining contractual term 3			2 years 8 months
Outstanding, aggregate intrinsic value	$ 56,840,920		$ 56,840,920
Outstanding and expected to vest, aggregate intrinsic value	52,937,345		52,937,345
Unrecognized compensation costs related to unvested units	$ 31,300		$ 31,300

Stock-Based Compensation, Emplo

Stock-Based Compensation, Employee Stock Purchase Plan (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018	Jun. 30, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	$ 22,820	$ 20,605	$ 64,973	$ 58,932
Risk-free interest rate	2.40%	1.10%	1.60%	0.80%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate	2.80%	3.00%	2.80%	3.00%
Unrecognized compensation costs related to unvested units	$ 162,600		$ 162,600
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition			2 years 8 months	2 years 8 months
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense	1,946	$ 2,053	$ 6,214	$ 6,830
Allocated Share-based Compensation Expense, Net of Tax	$ 20,874	$ 18,552	$ 58,759	$ 52,102
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum	2.60%	1.50%	2.60%	1.50%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum	27.50%	20.50%	19.60%	19.10%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum	28.91%	20.70%	32.69%	24.70%
Share Based Compensation Arrangement By Share Based Payment Award, Fair Value Assumptions, Expected Dividend Rate, Maximum	3.05%	3.10%	3.14%	3.40%
Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	$ 3,000	$ 2,200	$ 8,300	$ 5,800
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	985,398,000		985,398,000		1,688,253,000
Allocated Share-based Compensation Expense	$ 77	99	$ 233	1,339
Unrecognized compensation costs related to unvested units	0		0
ESP Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	$ 3,209	$ 2,560	$ 7,760	$ 6,594
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	6 months	6 months	6 months	6 months
Unrecognized compensation costs related to unvested units	$ 5,300		$ 5,300
Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	19,534	$ 17,946
Cost of Sales [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	2,613	2,575	7,281	$ 7,461
Cost of Sales [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	8	35	28	196
Cost of Sales [Member] | ESP Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	654	537	1,656	1,482
Cost of Sales [Member] | Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	1,951	2,003	5,597	5,783
Research and Development Expense [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	11,062	10,077	30,758	28,061
Research and Development Expense [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	5	13	27	507
Research and Development Expense [Member] | ESP Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	1,658	1,339	3,948	3,342
Research and Development Expense [Member] | Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	9,399	8,725	$ 26,783	$ 24,212
General and Administrative Expense [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	9,145	7,953
General and Administrative Expense [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	64	51
General and Administrative Expense [Member] | ESP Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	897	684
General and Administrative Expense [Member] | Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	$ 8,184	$ 7,218

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018
Numerator for basic earnings per share and diluted earnings per share
Net income	$ 130,613	$ 193,627	$ 459,928	$ 273,146
Denominator for basic earnings per share	273,221,000	280,850,000	275,831,000	281,525,000
Effect of dilutive securities
Stock options, ESPP and RSUs	3,389,000	5,031,000	3,849,000	4,696,000
Denominator for diluted earnings per share	276,610,000	285,881,000	279,680,000	286,221,000
Earnings per share, Basic (per share)	$ 0.48	$ 0.69	$ 1.67	$ 0.97
Earnings per share, Diluted (per share)	$ 0.47	$ 0.68	$ 1.64	$ 0.95
Antidilutive securities excluded from computation of earnings per share	0	0	0	0

Segment Information (Details)

Segment Information (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 30, 2019USD ($)customers	Mar. 31, 2018USD ($)	Mar. 30, 2019USD ($)	Mar. 31, 2018USD ($)	Jun. 30, 2018USD ($)
Segment Reporting Information [Line Items]
Number of Reportable Segments | customers	1
Revenues	$ 542,383	$ 648,599	$ 1,757,784	$ 1,846,913
Long-lived assets	571,955		571,955		$ 579,364
United States [Member]
Segment Reporting Information [Line Items]
Revenues	63,970	75,760	200,944	223,021
Long-lived assets	359,743		359,743		361,432
China [Member]
Segment Reporting Information [Line Items]
Revenues	183,753	219,160	611,768	662,114
Rest of Asia [Member]
Segment Reporting Information [Line Items]
Revenues	176,396	222,207	583,616	586,109
Europe [Member]
Segment Reporting Information [Line Items]
Revenues	104,124	114,254	316,155	329,939
Philippines [Member]
Segment Reporting Information [Line Items]
Long-lived assets	110,214		110,214		120,657
Rest of World [Member]
Segment Reporting Information [Line Items]
Revenues	14,140	$ 17,218	45,301	$ 45,730
Long-lived assets	$ 101,998		$ 101,998		$ 97,275

Comprehensive Income Loss Accum

Comprehensive Income Loss Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Net of Tax			$ (14,985)	$ (9,890)
Other Comprehensive Income (Loss), before Reclassifications, before Tax			2,464	(1,695)
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax			2,483	(1,680)
Other Comprehensive Income (Loss), Tax			(432)	61
Other comprehensive income (loss), net	$ 866	$ (1,412)	4,515	(3,314)
Accumulated Other Comprehensive Income (Loss), Net of Tax	(10,470)	(13,204)	(10,470)	(13,204)
Unrealized Holding Gains (Losses) on Intercompany Receivables [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Net of Tax			(6,280)
Other Comprehensive Income (Loss), before Reclassifications, before Tax			0	0
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax			0	0
Other Comprehensive Income (Loss), Tax			0	0
Other comprehensive income (loss), net			0	0
Accumulated Other Comprehensive Income (Loss), Net of Tax	(6,280)	(6,280)	(6,280)	(6,280)
Accumulated Defined Benefit Plans Adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Net of Tax			(2,516)	(1,258)
Other Comprehensive Income (Loss), before Reclassifications, before Tax			0	0
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax			292	154
Other Comprehensive Income (Loss), Tax			(60)	(168)
Other comprehensive income (loss), net			232	(14)
Accumulated Other Comprehensive Income (Loss), Net of Tax	(2,284)	(1,272)	(2,284)	(1,272)
Accumulated Translation Adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Net of Tax			(1,136)	(1,136)
Other Comprehensive Income (Loss), before Reclassifications, before Tax			0	0
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax			0	0
Other Comprehensive Income (Loss), Tax				0
Other comprehensive income (loss), net			0	0
Accumulated Other Comprehensive Income (Loss), Net of Tax	(1,136)	(1,136)	(1,136)	(1,136)
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Net of Tax			(1,383)	18
Other Comprehensive Income (Loss), before Reclassifications, before Tax			(783)	2,012
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax			2,191	(1,834)
Other Comprehensive Income (Loss), Tax			(241)	(45)
Other comprehensive income (loss), net			1,167	133
Accumulated Other Comprehensive Income (Loss), Net of Tax	(216)	151	(216)	151
Unrealized Holding Gains (losses) on Available-for-sale Investments [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Net of Tax			(3,670)	(1,234)
Other Comprehensive Income (Loss), before Reclassifications, before Tax			3,247	(3,707)
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax			0	0
Other Comprehensive Income (Loss), Tax			(131)	274
Other comprehensive income (loss), net			3,116	(3,433)
Accumulated Other Comprehensive Income (Loss), Net of Tax	$ (554)	$ (4,667)	$ (554)	$ (4,667)

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended		12 Months Ended
	Mar. 30, 2019	Dec. 29, 2018	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018	Jun. 24, 2017
Effective Income Tax Rate Reconcilliation, Share-based Compensation, Excess Tax Benefit, Amount [Line Items]
Unrecognized Tax Benefits, Interest on Income Taxes Expense			$ 13,100
Effective Income Tax Rate Reconciliation, Share-based Compensation, Excess Tax Benefit, Amount			8,300
Unrecognized Tax Benefits, Period Increase (Decrease)				$ 448,000
Advance payments for audit and post-audit year tax					$ 140,700
Interest payment on advance payments for audit and post-audit year tax					37,400
Effective Income Tax Rate Reconciliation, Share-based Compensation, Excess Tax Benefit, Amount			4,600
Income tax provision (benefit)	$ 29,845		$ 28,677	$ 116,843	$ 328,038
Effective Income Tax Rate Reconciliation, Percent	18.60%		12.90%	20.30%	54.60%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	21.00%				0.00%	35.00%
Effective Income Tax Reconciliation, Deferred Tax Remeasurement			$ 13,700
Effective Income Tax Reconciliation, Transition Tax			236,900	$ 4,100
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount		$ 22,100
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent	3.80%
Effective Income Tax Reconciliation, Interest Accruals	$ 5,700		$ 5,100	15,100
Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount	$ 21,000			$ 4,800

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Mar. 31, 2018
Business Acquisition, Contingent Consideration [Line Items]
Business Combination, Contingent Consideration, Liability	$ 8,000	$ 16,000

Common Stock Repurchases (Detai

Common Stock Repurchases (Details) - USD ($) $ in Thousands, shares in Millions	3 Months Ended		9 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018	Oct. 30, 2018	Jul. 20, 2017
Equity, Class of Treasury Stock [Line Items]
Stock Repurchased During Period, Shares			8
Stock Repurchased During Period, Value			$ 437,000
Stock repurchase program, authorized amount					$ 2,000,000	$ 1,000,000
Value of common stock repurchased	$ 116,991	$ 127,700	437,047	$ 279,946
Stock repurchase program, remaining authorized amount	$ 1,217,100		$ 1,217,100

Acquisitions (Details)

Acquisitions (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018	Jun. 30, 2018
Business Acquisition [Line Items]
Payments to Acquire Businesses, Net of Cash Acquired	$ 57,800	$ 2,949	$ 57,773
Business Combination, Contingent Consideration, Liability	16,000		16,000	$ 8,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	26,000		26,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill	10,500		10,500
Goodwill	$ 41,889	$ 532,251	$ 41,889	$ 532,251

Goodwill and Intangible Assets,

Goodwill and Intangible Assets, Goodwill (Details) - USD ($) $ in Thousands	Mar. 30, 2019	Jun. 30, 2018	Mar. 31, 2018
Goodwill [Line Items]
Goodwill	$ 532,251	$ 532,251	$ 41,889

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets, Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018	Jun. 30, 2018
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Finite-Lived Intangible Assets, Gross	$ 617,825		$ 617,825		$ 613,599
Accumulated Amortization	559,579		559,579		538,143
Net	58,246		58,246		75,456
Intangible Assets, Gross	620,615		620,615		616,389
Total purchased intangible assets	61,036		61,036		78,246
Cost, Amortization	5,368	$ 12,101	19,151	$ 34,305
Intangible asset amortization	756	876	2,285	3,623
Intangible Asset Amortization Expense	6,124	$ 12,977	21,436	$ 37,928
Future amortization expense [Abstract]
Remaining three months of 2017	4,793		4,793
2019	15,068		15,068
2020	13,368		13,368
2021	7,689		7,689
2022	7,205		7,205
Thereafter	10,123		10,123
Net	58,246		58,246		75,456
Intellectual Property [Member]
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Finite-Lived Intangible Assets, Gross	488,846		488,846		485,465
Accumulated Amortization	443,020		443,020		423,869
Net	45,826		45,826		61,596
Future amortization expense [Abstract]
Net	45,826		45,826		61,596
Customer relationships [Member]
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Finite-Lived Intangible Assets, Gross	116,505		116,505		116,294
Accumulated Amortization	105,229		105,229		103,217
Net	11,276		11,276		13,077
Future amortization expense [Abstract]
Net	11,276		11,276		13,077
Tradename [Member]
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Finite-Lived Intangible Assets, Gross	9,974		9,974		9,340
Accumulated Amortization	8,830		8,830		8,588
Net	1,144		1,144		752
Future amortization expense [Abstract]
Net	1,144		1,144		752
Patents [Member]
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Finite-Lived Intangible Assets, Gross	2,500		2,500		2,500
Accumulated Amortization	2,500		2,500		2,469
Net	0		0		31
Future amortization expense [Abstract]
Net	0		0		31
In Process Research and Development [Member]
Intangible Assets, Net (Excluding Goodwill) [Abstract]
IPR&D	$ 2,790		$ 2,790		$ 2,790

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018
Long Lived Assets Held-for-sale [Line Items]
Impairment of long-lived assets	$ 0	$ 0	$ 753	$ 892
Gain (Loss) on Disposition of Property Plant Equipment			$ (3,324)	$ (572)

Restructuring Activities (Detai

Restructuring Activities (Details) - $ / shares	3 Months Ended		9 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018
Restructuring Cost and Reserve [Line Items]
Earnings per share, Diluted (per share)	$ 0.47	$ 0.68	$ 1.64	$ 0.95

Restructuring Activities Change

Restructuring Activities Change in Estimate (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018
Change in Accounting Estimate [Line Items]
Operating Income (Loss)	$ 157,140	$ 224,838	$ 573,527	$ 611,052
Net income	$ 130,613	$ 193,627	$ 459,928	$ 273,146
Basic	$ 0.48	$ 0.69	$ 1.67	$ 0.97
Diluted	$ 0.47	$ 0.68	$ 1.64	$ 0.95

Uncategorized Items - mxim-2019

Label	Element	Value
Stock Issued During Period, Value, Stock Options Exercised	us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised	$ 7,715,000
Stock Issued During Period, Value, Stock Options Exercised	us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised	26,384,000
Stock Issued During Period, Value, Stock Options Exercised	us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised	5,143,000
Dividends	us-gaap_Dividends	0
Dividends	us-gaap_Dividends	1.14
Dividends	us-gaap_Dividends	0.46
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	2,202,694,000
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	1,950,991,000
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	1,662,747,000
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	(9,641,000)
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	(21,161,000)
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	(9,582,000)
Stock Issued During Period, Value, Employee Stock Purchase Plan	us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	0
Stock Issued During Period, Value, Employee Stock Purchase Plan	us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	14,975,000
Stock Issued During Period, Value, Employee Stock Purchase Plan	us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	0
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	us-gaap_ProfitLoss	193,627,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	us-gaap_ProfitLoss	273,146,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	us-gaap_ProfitLoss	130,613,000
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	117,883,000
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	320,766,000
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	125,566,000
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	20,587,000
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	58,979,000
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	$ 22,850,000
Common Stock, Shares, Outstanding	us-gaap_CommonStockSharesOutstanding	279,979,000
Retained Earnings [Member]
Treasury Stock, Value, Acquired, Par Value Method	us-gaap_TreasuryStockValueAcquiredParValueMethod	$ (109,039,000)
Treasury Stock, Value, Acquired, Par Value Method	us-gaap_TreasuryStockValueAcquiredParValueMethod	(200,769,000)
Treasury Stock, Value, Acquired, Par Value Method	us-gaap_TreasuryStockValueAcquiredParValueMethod	(98,580,000)
Stock Issued During Period, Value, Stock Options Exercised	us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised	0
Stock Issued During Period, Value, Stock Options Exercised	us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised	0
Stock Issued During Period, Value, Stock Options Exercised	us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised	0
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	2,212,301,000
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	1,963,912,000
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	1,672,938,000
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0
Stock Issued During Period, Value, Employee Stock Purchase Plan	us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	0
Stock Issued During Period, Value, Employee Stock Purchase Plan	us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	0
Stock Issued During Period, Value, Employee Stock Purchase Plan	us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	0
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	us-gaap_ProfitLoss	193,627,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	us-gaap_ProfitLoss	273,146,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	us-gaap_ProfitLoss	130,613,000
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	117,883,000
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	320,766,000
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	125,566,000
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	0
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	0
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	0
AOCI Attributable to Parent [Member]
Treasury Stock, Value, Acquired, Par Value Method	us-gaap_TreasuryStockValueAcquiredParValueMethod	0
Treasury Stock, Value, Acquired, Par Value Method	us-gaap_TreasuryStockValueAcquiredParValueMethod	0
Treasury Stock, Value, Acquired, Par Value Method	us-gaap_TreasuryStockValueAcquiredParValueMethod	0
Stock Issued During Period, Value, Stock Options Exercised	us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised	0
Stock Issued During Period, Value, Stock Options Exercised	us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised	0
Stock Issued During Period, Value, Stock Options Exercised	us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised	0
Other Comprehensive Income (Loss), Net of Tax	us-gaap_OtherComprehensiveIncomeLossNetOfTax	(1,412,000)
Other Comprehensive Income (Loss), Net of Tax	us-gaap_OtherComprehensiveIncomeLossNetOfTax	(3,314,000)
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	(9,890,000)
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	(13,204,000)
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	(13,204,000)
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	(10,470,000)
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0
Stock Issued During Period, Value, Employee Stock Purchase Plan	us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	0
Stock Issued During Period, Value, Employee Stock Purchase Plan	us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	0
Stock Issued During Period, Value, Employee Stock Purchase Plan	us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	0
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	0
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	0
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	0
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	0
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	0
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	0
Additional Paid-in Capital [Member]
Treasury Stock, Value, Acquired, Par Value Method	us-gaap_TreasuryStockValueAcquiredParValueMethod	(18,659,000)
Treasury Stock, Value, Acquired, Par Value Method	us-gaap_TreasuryStockValueAcquiredParValueMethod	(79,174,000)
Treasury Stock, Value, Acquired, Par Value Method	us-gaap_TreasuryStockValueAcquiredParValueMethod	(18,411,000)
Stock Issued During Period, Value, Stock Options Exercised	us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised	7,714,000
Stock Issued During Period, Value, Stock Options Exercised	us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised	26,382,000
Stock Issued During Period, Value, Stock Options Exercised	us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised	5,143,000
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	(9,642,000)
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	(21,162,000)
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	(9,582,000)
Stock Issued During Period, Value, Employee Stock Purchase Plan	us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	0
Stock Issued During Period, Value, Employee Stock Purchase Plan	us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	14,975,000
Stock Issued During Period, Value, Employee Stock Purchase Plan	us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	0
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	0
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	0
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	0
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	20,587,000
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	58,979,000
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	22,850,000
Common Stock [Member]
Treasury Stock, Value, Acquired, Par Value Method	us-gaap_TreasuryStockValueAcquiredParValueMethod	(2,000)
Treasury Stock, Value, Acquired, Par Value Method	us-gaap_TreasuryStockValueAcquiredParValueMethod	(3,000)
Treasury Stock, Value, Acquired, Par Value Method	us-gaap_TreasuryStockValueAcquiredParValueMethod	$ 0
Treasury Stock, Shares, Acquired	us-gaap_TreasuryStockSharesAcquired	2,140,000
Treasury Stock, Shares, Acquired	us-gaap_TreasuryStockSharesAcquired	5,286,000
Treasury Stock, Shares, Acquired	us-gaap_TreasuryStockSharesAcquired	2,210,000
Stock Issued During Period, Value, Stock Options Exercised	us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised	$ 1,000
Stock Issued During Period, Value, Stock Options Exercised	us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised	2,000
Stock Issued During Period, Value, Stock Options Exercised	us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised	0
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	283,000
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	283,000
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	283,000
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	279,000
Stockholders' Equity, Other	us-gaap_StockholdersEquityOther	279,000
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	1,000
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	1,000
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	$ 0
Stock Issued During Period, Shares, Employee Stock Purchase Plans	us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	0
Stock Issued During Period, Shares, Employee Stock Purchase Plans	us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	416,000
Stock Issued During Period, Shares, Employee Stock Purchase Plans	us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	0
Stock Issued During Period, Value, Employee Stock Ownership Plan	us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	$ 0
Stock Issued During Period, Value, Employee Stock Ownership Plan	us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	0
Stock Issued During Period, Value, Employee Stock Ownership Plan	us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	0
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	0
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	0
Dividends, Common Stock, Cash	us-gaap_DividendsCommonStockCash	$ 0
Stock Issued During Period, Shares, Other	us-gaap_StockIssuedDuringPeriodSharesOther	294,000
Stock Issued During Period, Shares, Other	us-gaap_StockIssuedDuringPeriodSharesOther	1,031,000
Stock Issued During Period, Shares, Other	us-gaap_StockIssuedDuringPeriodSharesOther	177,000
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	$ 0
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	0
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition	us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	$ 0
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	387,000
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	906,000
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures	us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	402,000